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As an integral part of the cell’s communication system, membrane proteins play an 
essential role in relaying signals between cells and their environment. For example, 
binding of ligand on the extracellular portion of a cell surface receptor induces 
conformational changes that are transmitted through the membrane and activate 
numerous signaling pathways. I have utilized negative stain electron microscopy and 
single particle analysis to investigate and characterize the structural dynamics of 
transmembrane protein machineries.  
The hormone leptin is a key regulator of metabolism and body weight. The leptin 
receptor (LepR) is a single pass transmembrane receptor that is capable of instigating 
intracellular signaling via the JAK/STAT pathway upon leptin binding to the 
extracellular side of LepR. Both stimulation and inhibition of LepR have implications in 
disease treatment and represent important drug targets. I characterized the architecture of 
the leptin/LepR signaling complex and proposed a mechanism of activation upon binding 
of ligand. LepR displays significant flexibility in a hinge region within the leptin binding 
domain while the C-terminal “legs” remain rigid. In the context of a liganded receptor, 
there is no flexibility at the hinge region and the C-terminal, membrane proximal “legs” 
become positioned in a certain orientation that we propose is a key mechanism for 
transmitting the signaling across the membrane. 
This work also characterizes a signaling complex between the µ-Opioid receptor (µ-OR) 
and its cognate Gi subunit. The results reveal the dynamic nature of the Gα subunit of Gi, 
which appears to be a common feature of G-protein activation. As opioid drugs are 
highly addictive and their clinical efficacy restricted, understanding the activation 




Chapter 1 Introduction 
1.1 Structure and Function on Membrane Proteins 
Membrane proteins are biologically very important groups of proteins because they 
connect the extracellular environment to the intracellular environment of the cell. 
Membrane proteins are involved in immune response and recognition, transport of 
molecules across the phospholipid bilayer, cell adhesion and signal transduction. There 
are two major categories of membrane proteins based on the membrane interaction - 
integral and peripheral. Integral membrane proteins are characterized by at least one 
membrane-spanning domain with many hydrophobic side chains in their amino acid 
composition, allowing them to make contact with the fatty acyl groups of the 
phospholipids. Integral membrane proteins penetrate the phospholipid bilayer through α-
helices or β-barrels, making these regions both structural and functional components of 
the cell membrane. On the other hand, the peripheral membrane proteins do not directly 
interact with the hydrophobic core of the phospholipid bilayer but instead are connected 
to the membrane through polar head groups (Lodish et al., 2000) (Figure 1-1). Ligand 
binding on the extracellular side of an integral membrane protein can lead to 
conformational changes, which are then transferred to the intracellular side, and the 
signal is converted to a physiological response. Membrane proteins comprise an 
extremely sophisticated set of cellular machineries whose intricate functions depend 




Figure 1-1 An illustration of different types of membrane – protein associations. 
There are two major groups of membrane-associated proteins, based on their interaction 
with the membrane. Peripherally associated proteins only make a contact with the 
membrane and have an access either to the intracellular or the extracellular space. 
Examples are protein-lipid interactions and glycolipid-anchor. The integral membrane 
proteins are mainly single or multiple pass proteins making access to both the 
extracellular and intracellular space. 
In addition, their specific protein fold has a crucial significance in positioning a precise 
set of amino acids at the ligand binding pocket, governing the interactions with 
extracellular signals. The three-dimensional structure of proteins changes upon 
interaction with environmental stimuli. Following reversible or irreversible series of 
chemical shifts in their three dimensional structure is a way of providing a mechanism for 
exertion and regulation of cell processes. Exactly how the integral membrane proteins are 
able to transmit an extracellular signal in the form of a conformational change through 
the membrane and initiate physiological response is still poorly understood.  
Although membrane proteins constitute about 30% of the proteome, their solved 
structures are highly underrepresented, making up only about 2% of the total structures in 














Figure 1-2 Number of known membrane protein structure in PDB up to date 
(http://blanco.biomol.uci.edu/mpstruc/listAll/list) 
 
The technical difficulties in expression, solubilization and purification are responsible for 
the low number of solved membrane protein structures. Recent advances in protein 
engineering had aided the successful crystallization of a few challenging membrane 
proteins, shedding new light into our understanding of structure-function relationship. 
1.2 Membrane proteins as signal transduction units 
A cell communicates with its environment by receiving, processing and responding to 
specific chemicals that can trigger signal transduction. The sensing and processing of 
stimuli is termed a signal transduction cascade whereby the cell is able to detect, amplify 
and integrate various external signals in order to generate diverse biological responses. 
For example, extracellular stimuli can modulate receptor and/or enzyme activity, ion-





Figure 1-3 Signal propagation diagram. 
A signal in the form of any stimuli is received by the cell surface receptor (reception), 
amplified by the second messengers and transduced to downstream signaling effectors. 
As a result, a cellular response is generated in the form of transcriptional activation, for 
example. 
The main principles of signal transduction can be summarized in (Figure 1-3). An 
environmental signal, termed primary messenger, arrives at the cell membrane and since 
it is usually unable to cross the membrane, it interacts with a cell-surface receptor. 
Following the receptor interaction, the signal is relayed to the cell by a way of a 
conformational change in the receptor protein and further converted into an intracellular 
chemical response. On the intracellular side and in the cytosol, the signal is usually 
amplified by other small molecules, termed secondary messengers. The secondary 
messengers stimulate downstream effector molecules which in turn are able to trigger a 
physiological response. Second messengers are very important in signal transduction 
because they not only amplify the signal generated by a few activated membrane 
receptors but also travel to a variety of cellular compartments and signal in multiple 








GMP (cGMP), calcium ion (Ca2+), inositol 1,4,5-triphosphate (IP3) and diacylglycerol 
(DAG) (Stryer 2002) (Figure 1-4).  
 
 
Figure 1-4 Structures of some important second messengers. 
The concentration of these small molecules changes in response to extracellular stimuli 
and since they are readily diffusible through other cellular compartments, they can 
modulate diverse biochemical processes in the cell. Moreover, many cell surface 
receptors share the same second messengers in multiple signaling pathways which can 
often lead to cross talk, affecting the local concentration of second messengers. It is 
important to mention, however, that cross talk can not only lead to more precise 
regulation of cellular activity but also it may cause potential problems if the second 
messengers are misinterpreted by the cell (Berg et al., 2002). In addition, this signaling 
cascade can be modulated by feedback mechanisms by which the cell’s response is able 
to inhibit or change the initial signal reception.  
Some small non-polar molecules such as certain hormones can diffuse through the cell 
membrane and instigate signaling. Most of the time, however, the cell surface receptors 
are responsible for making the first contact with the environmental stimuli. Thus, large 
and polar molecules that are otherwise incapable of entering the cell are transmitting the 
information they are carrying into the intracellular space.  
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In addition, information transduction can be in the form of protein phosphorylation where 
second messengers activate protein kinases. In this case, an enzyme transfers a 
phosphoryl group from an adenosine triphosphate (ATP) to a serine, threonine or tyrosine 
residue of a protein. Protein phosphatases may reverse this change by dephosphorylating 
the protein and terminating the signal (Figure 1-5). 
Figure 1-5 Phosphate transfer. 
Graphical representation of the γ phosphate transfer from an adenosine tri-phosphate 
(ATP) to a Serine, a Threonine or a Tyrosine residue on a protein. 
Signal termination is needed in order for the cell to respond to new signals. However, 
when the signal cascade fails to be terminated, the cell can undergo uncontrolled growth 
or even become cancerous. Other mechanisms for signal transduction termination can be 
exerted in the form of negative feedback processes. A well-documented example of 
negative feedback used as a regulatory mechanism is the signaling of insulin. Insulin 
signals to liver cells to reduce the production and release of glucose thereby contributing 
to lowered blood glucose levels. In addition, insulin signals to fat and muscle to take up 
glucose at a greater rate. Insulin binds and activates transmembrane receptor tyrosine 
kinases which upon activation are phosphorylated on certain Tyrosine residues. Tyrosine 
phosphatases (PTPases) are enzymes capable of dephosphorylating the receptor and 
attenuating the insulin-induced signaling. A negative feedback mechanism of insulin 
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signaling is the insulin-mediated transcriptional activation of PTPases, which 
dephosphorylate the insulin receptors and attenuating the signal (James et al., 2005; 
Saltiel and Kahn, 2001). 
Some integral membrane proteins serve as ion channels, cellular transporters of cargo 
binding to them, energy pumps, enzymes catalyzing reactions at the cell membrane 
surfaces or receptors that transmit chemical information. The work in this thesis 
concentrates on the topics of how two different classes of integral membrane receptors, 
specifically, single and multiple pass receptors, are able to communicate signals through 
the cell membrane in response to extracellular stimuli and instigate physiological 
processes. Understanding the conformational dynamics of how these complicated 
membrane machineries are able to transduce information through the membrane is the 
primary aim of my studies. 
1.3 Cytokines and signal transduction 
Cytokines and their receptors  
The formation of a ligand-receptor complex at the membrane is the prerequisite for 
instigating intracellular signaling cascades. Cytokines are pleiotropic signaling molecules 
that regulate important biological responses such as immune response, cell proliferation, 
differentiation and apoptosis (Wang et al., 2009). Both ligands and receptors that belong 
to the cytokine superfamily share common structural features. Class 1 cytokines are most 
abundant and are characterized by a typical “four-helical” bundle fold (Bazan, 1990a) 
with their hydrophilic residues oriented on the outside and the hydrophobic ones forming 
the core of the helical bundle (Sprang, 1993). To signal, cytokines bind to their 
corresponding transmembrane receptors and instigate intracellular downstream signaling 
by stimulating an array of cytosolic molecules. According to their structure, the cytokine 
receptors can also be classified into several groups - class I, class II, TNF receptor 
superfamily, IL-1  and chemokine receptor family with class I being the largest 
(Thomson and Lotze, 2003). Because of their structural similarities, receptors can engage 
similar ligands, thus, involving redundant biological processes. Receptors belonging to 
this class, also known as the hematopoietin receptor family, are single pass 
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transmembrane proteins having an N-terminal extracellular, ligand-binding portion and 
C-terminal intracellular tail. Members of this family include granulocyte colony 
stimulating factor receptor (GCSF-R), leukemia inhibitory factor receptor (LIF-R), leptin 
receptor (Lep-R) and glycoprotein 130 (gp130) (Baumann et al., 1996; Tamada et al., 
2006; Wang et al., 2009) and others. The extracellular regions of class I cytokine 
receptors are grouped into modules, consisting of an array of fibronectin type-III (FNIII) 
fold domains. A membrane distal cytokine homology region (CHR) motif is associated 
with ligand-binding and is necessary for signaling (Eastell et al., 1998) (Bazan, 1990b; de 
Vos et al., 1992). In some members of this class such as the human Growth Hormone 
receptor (hGHR) and the erythropoietin receptor (EPOR), the basic CHR is sufficient to 
engage the ligand and initiate receptor homodimerization (de Vos et al., 1992; Sprecher 
et al., 1998). However, an Ig-like domain is an additional prerequisite for ligand-binding 
and signal induction in other cytokine receptors such as gp130, GCSF-R, LIF-R and 
LepR (Chow et al., 2001; Huyton et al., 2007; Tamada et al., 2006; Fong et al., 1998). 
Additional membrane-proximal FNIII type domains connect the ligand-binding region to 
the membrane. Following a single transmembrane helix, these receptors are characterized 
by a short intracellular tail also marked by conserved regions. Box 1 and box 2 motifs, for 
example, found in close proximity to the membrane, serve as docking sites for 
constitutively bound kinases, required to propagate the signal initiated by ligand binding 
(Tanner et al., 1995; Usacheva et al., 2002) (Figure 1-6a). Class I cytokine receptors are 
not active kinases themselves. Instead, they rely on constitutively bound Janus kinases 
(JAK’s) to execute the tyrosine kinase activity needed for signal transduction (Darnell et 
al., 1994; Leonard and O'Shea, 1998; Murray, 2007). Ligand-binding on the outside is 
followed by a conformational change which results in a critical re-orientation of the 




Figure 1-6 Overall domain organization of some class I cytokine receptors and their 
signal transduction. 
a, Domain organization of class I cytokine receptors – receptors belonging to class I are 
composed of an array of fibronectin III fold domains at their extracellular region; 
cytokine homology region (CHR) and immunoglobulin-like domain are involved in 
ligand binding; conserved Box 1, 2 motifs on the intracellular receptor tails serve as 
Janus Kinases binding sites; b, Signaling pathways activated by class I cytokines – 
Jak/Stat pathway is the primary pathway instigated upon ligand biding to class I cytokine 
receptors. Secondary signaling pathways involved in growth, reproduction and energy 
expenditure can also be activated as a result of cytokine signaling. (b, Courtesy of 
Georgios Skiniotis) 
Once activated, the JAKs phosphorylate certain residues on the receptor tail which serve 
as docking sites for a second family of proteins, the signal transducer and activator of 
transcription (STAT) proteins. STATs bind to the receptor tail and their JAK-mediated 
phosphorylation and activation results in subsequent dissociation from the receptor and 
dimerization in the cytoplasm. In turn, STATs translocate into the nucleus and activate 
transcription of variety of genes (Ihle, 2001; Schindler et al., 2007). In addition to the 
JAK-STAT signaling pathway, the class I cytokine receptor family can instigate and 
signal through many other pathways such as the PI3K kinase and/or the RAS/MAP 
kinase pathway  (Cantley, 2002; Dong et al., 2002). However, how the structural changes 
upon ligand binding are transmitted on the other side of the membrane to instigate 
signaling as well as the structural dynamics surrounding the JAK-STAT communication 





Janus kinases (JAKs), a distinct family of tyrosine kinases, are required for signal 
transduction for class I cytokine receptors (Baker et al., 2007; Darnell et al., 1994). In 
addition to JAKs’ role in cytokine signal transduction, it has been suggested that they 
may promote cell surface expression of cytokine receptors by binding to the receptor 
(Huang et al., 2001). The JAK family includes four members, JAK1 (Wilks et al., 1991), 
JAK2 (Harpur et al., 1992), JAK3 (Rane and Reddy, 1994) and TYK2 (Firmbach-Kraft et 
al., 1990).  
According to their sequence similarities there are seven regions of homology named Jak 
homology (JH) regions 1-7 (Figure 1-7a) (Yeh and Pellegrini, 1999). The two carboxy 
terminal JH domains 1 and 2 retain high homology to tyrosine kinases. However, only 
JH1 retains kinase activity while JH2 lacks critical functional amino acids rendering it a 
pseudo-kinase (Duhe and Farrar, 1995; Feng et al., 1997). The pseudo-kinase domain has 
an essential regulatory function as a cytokine-inducible switch and can regulate JAK2 
activation. Despite the lack of structural information, biochemical studies suggest that 
regulation of the kinase activity is mediated possibly through an intramolecular 
interaction between JH1 and JH2 (Saharinen and Silvennoinen, 2002). The N-terminal 
region contains a Four-point-one/Ezrin/Radixin/Moesin (FERM) (JH4-JH7 and half of 
JH4) domain, which is responsible for receptor recognition and association (Frank et al., 
1995; Zhao et al., 1995). Mutagenesis and kinase chimeric experiments combining 
regions from different JAKs have suggested that a minimum receptor recognition region 
may be concentrated to the first 200 residues of the N-terminus (Feng et al., 1997; 
Richter et al., 1998). A Src homology-2 like (SH2-like) domain (JH3-JH4) is located 
between the FERM and the pseudo-kinase domains (Figure 1-7a)(Wilks et al., 1991). The 
SH2-like domain does not function as a conventional phosphotyrosine binding domain 
and may be involved in mediating association with the membrane proximal regions of the 
cytokine receptors but its exact functions remain unclear (Haan et al, 2006).  
Ligand binding to the extracellular site of cytokine/growth factor receptors results in 
juxtaposition of JAKs leading to their auto- trans-phosphorylation on key tyrosine 
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residues (Remy et al., 1999). Activation of JAKs, in turn mediates downstream signaling 
through phosphorylating specific tyrosine residues on the receptor tail that serve as 
docking sites for SH2 domains containing molecules such as signal transducers and 
activators of transcription (STATs) (Figure 1-6b).  
Mutations in JAKs that lead to the constitutive activation of the kinase domain and cause 
serious pathological diseases such as myeoloproliferative neoplasms (MPNs) and 
leukemia (Haan et al., 2010; Vainchenker et al., 2011), imply negative regulation of JH2 
on JAK activity. However, in a recent study it was suggested that JH2 may also have a 
positive regulatory function because a JH2 deletion mutant was able to maintain JAK2 
basal activity but could not be further stimulated by the cytokine (Ungureanu et al., 
2011). The crystal structures of both JH1 (Jak3) and JH2 (Jak2) are available 
(Bandaranayake et al., 2012; Boggon et al., 2005) although the precise regulatory nature 
of interactions of JH2 on JH1 remains elusive. In addition, it is also possible that in the 
context of preformed receptor dimers, constitutively bound JAKs interact in an inhibitory 
manner, through their JH2 domains. Upon ligand binding, conformational changes in the 
receptor perhaps lead to stimulatory rearrangements within the JH2 domains of JAKs and 
activate downstream signaling. 
How the structural information is carried from the activated receptor to JAK is still 
poorly understood due to the lack of structural information on both full-length JAK and 




Figure 1-7 Domain organization in JAKs and STATs 
a., representation of Janus kinases (JAKs) domain organization showing JAK homology 
domains (JH) 1-7, based on the sequence similarities of the four known JAKs. N-terminal 
FERM domain comprises regions JH7 through JH5. Src homology 2-like domain (SH2-
like) spans the JH3-JH4 region. JH2 is the pseudo-kinase domain and JH1 is the C-
terminal kinase.. b. Signal transducer and activator of transcription (STAT) domain 
organization – the six Stats share several functional domains. An amino terminal 
oligomerization domain, a coiled-cooil domain, a DNA-bidning domain, an SH2 domain 
and a transcriptional activation domain at the C-terminus. 
Structural information of the cytokine/receptor/JAK complex could provide important 
information regarding the structural rearrangements that take place upon ligand binding 
and lead to the activation of the Janus kinases.  
Signal transducers and activators of transcription and their targets 
The signal transducers and activators of transcription (STATs) are a family of proteins 
consisting of seven members in mammalian cells and originally described by Darnell et 
al. (Darnell et al., 1994) as ligand-induced transcription factors. Different members of the 
STAT family share domain organization. There are a total of seven domains that exhibit 
modular structure (Figure 1-7b) – a conserved N-terminal domain, a coiled-coil domain, a 
JH1JH2JH3JH4JH5JH6JH7
Janus Kinases (Jak1, Jak2, Jak3, Tyk2)
STAT Proteins (Stat1, Stat2, Stat3, Stat4, Stat5a,b, Stat6)
STAT
oligomerization 









DNA-binding domain, a linker region, a tyrosine activation and a C-terminal activation 
domain (Jatiani et al., 2010). The amino terminal domain is critical for STATs’ function 
as small deletions in this region lead to inability of the STATs to become phosphorylated. 
In addition, this domain plays a role in nuclear import, export, receptor binding and 
interaction with the DNA binding domain (Mertens et al., 2006). The coiled-coil domain 
is involved in receptor binding and interaction with regulatory proteins (Kisseleva et al., 
2002). The DNA binding domain, as its name implies is involved in binding to DNA to 
activate transcription and is highly conserved among STATs. A linker region is located 
between the DNA binding domain and the SH2 dimerization domain to ensure proper 
conformation. The SH2 domain is critical for signaling and the recruitment of STATs to 
the activated receptor complexes and is highly conserved. Through this domain STATs 
can homodimerize and heterodimerize and in turn localize to the nucleus and bind DNA. 
The C-terminal transactivation domain is the most variable between different STATs and 
it modulates transcriptional activation of target genes (Figure 1-7b) (Jatiani et al., 2010; 
Neculai et al., 2005). 
When cells are resting, STATs exist as a preformed homodimers in the cytoplasm 
(Mertens et al., 2006). Upon ligand binding to receptor, intracellularly bound JAKs also 
become activated and phosphorylate specific tyrosine residues on the receptor tails. The 
phosphotyrosyl residues, in turn, serve to direct the SH2-dependent recruitment of 
STATs to the receptor. Once recruited to the receptor tails, STATs become 
phosphorylated by the activated JAKs and get released into the cytoplasm where they 
rearrange into anti-parallel dimers through the SH2 domains. Furthermore, STAT dimers 
translocate to the nucleus, bind certain enhancer elements and initiate gene transcription 
(Baker et al., 2007; Schindler et al., 2007).  
Moreover, Stats are capable of forming not only homodimers but also heterodimers, 
tetramers and other higher order complexes (Ward et al., 2000). It has been suggested 
that JAKs do not exhibit specificity for certain STATs because the same STATs can get 
activated at different receptors, associated with different JAKs (Darnell, 1997). In 
addition, some experiments with chimeric receptor molecules with different JAK binding 
sites but with the same STAT-binding sites were found to activate the same STATs 
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(Kotenko et al., 1996). Therefore, it is likely that the specificity for STATs depends on 
their docking sites on the receptors rather than the JAK kinases. There are multiple 
details that yet remain to be resolved in the JAK-STAT signaling pathway which would 
require further structural and mechanistic information. 
Other signaling pathways activated by cytokines 
In addition to the JAK-STAT pathway, cytokines are able to activate multiple other 
signal transduction pathways, exerting their divergent actions. For example, it has been 
suggested that the protein tyrosine phosphatase SHP-2 is implicated in mediating the 
leptin receptor activation of MAPK (Bjorbaek et al., 1999). In addition, some cytokines 
can also induce JAK/STAT mediated phosphorylation of ERK and AKT (Saxena et al., 
2007). Moreover, experimental evidence suggests that AKT can also be activated via 
cytokine mediated stimulation of the lipid kinase phosphoinositol 3 kinase (PI3K) (Reddy 
et al., 2000). 
Negative regulation of cytokine pathways 
Excessive signaling and overstimulation of cytokine signaling can lead to autoimmune 
disorders and cancer. Therefore, it is crucial for the cell to exert tight regulation on the 
signaling pathways mediated by JAK/STAT. There are a few ways in which the cell is 
capable of turning off the signaling, initiated by cytokines. Src-homology phosphatase 
(SHP-1) can directly dephosphorylate JAKs. Three protein families, particularly the 
suppressors of cytokine signaling (SOCS), protein inhibitors of activated STATs (PIAS) 
and cytoplasmic phosphatases have been implicated in the negative regulation of 
cytokine signaling. SOCS are found to be able to compete with STATs for binding to the 
receptor (Seki et al., 2002) or directly interact with JAKs (Khwaja, 2006) to mediate 
negative regulation of cytokine signaling. PIAS proteins, on the other hand, can regulate 
the amount of available STAT for enhancing the transcription of available genes by 
directly binding to STAT dimers (Baker et al., 2007). Protein tyrosine phosphatases 
(PTP) can negatively regulate JAK-STAT pathways by dephosphorylating tyrosine 
residues (Pallen et al., 1992). The mechanism of regulation involves dephosphorylation 
 
15 
of both JAKs and activated receptors, thereby preventing STATs from associating with 
the receptors and their activation.  
1.4 G-protein Coupled receptors as signal transduction units 
GPCRs are by far the largest family of membrane proteins, with more than 800 members 
in the human genome, and are involved in signal transduction that mediates the majority 
of cellular responses to a variety of ligands, ranging from nucleotides and amines, to 
peptides and hormones (Strader et al., 1994). In addition, GPCRs are responsible for 
vision, olfaction and taste and many other vital physiological events. A seven 
transmembrane (7TM), α-helical region spanning the membrane with an extracellular 
amino terminal and a carboxy intracellular tail is a characteristic signature of all GPCRs. 
There are five main families of GPCRs grouped based on their amino acid sequence and 
three-dimensional structural similarities: rhodopsin, secretin, glutamate (family A, B and 
C, respectively), adhesion and Frizzled/Taste2 (Fredriksson et al., 2003). Although, the 
receptors are very similar in their overall topology, GPCRs, like cytokine receptors, can 
be involved in a variety of unique signal transduction pathways, both dependent and 
independent of different associated G-protein subtypes. 
GPCR overall structural topology 
There are three extracellular and three intracellular loops connecting the 7TM α-helices 
which also represent the most variable regions among the family of GPCRs (Kobilka, 
2007). The extracellular loops contain conserved cysteine residues that are capable of 
forming disulfide bonds to stabilize the receptor tertiary structure. In addition, the 
extracellular domain contains asparagine residues and motifs for N-glycosylation which 
are implicated in intracellular trafficking of the receptors to the membrane (Tuteja, 2009). 
The greatest diversity is displayed at the amino termini where the sequence can range in 
size from few amino acids for the monoamine and peptide receptors to few hundred 
amino acids for the glutamate receptors (Kobilka, 2007). In contrast, the greatest 
structural homology in GPCRs is within the transmembrane helical segments. The α-
helices embedded in the membrane are arranged to form a tight, ring-shaped hydrophobic 
structure which is important for receptor stability and ligand-induced conformational 
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changes. Thus, any mutations or perturbations in this structural organization could be 
deleterious.  
Common modes of activation of GPCRs 
As in other transmembrane signaling systems, the interaction between ligand and the 
extracellular portion of a GPCR is the prerequisite event in signal transduction. The 
major course of events upon ligand binding can be depicted in Figure 1.8.  Once the 
ligand and the receptor form the signaling complex, the receptor is activated and ready to 
propagate the information in terms of structural rearrangement through the membrane. 
 
Figure 1-8 Signal Transduction through GPCRs. 
Ligand binds to the extracellular side of the receptor and activates the receptor. GDP is 
released and GTP comes in, activating the G-protein, bound on the intracellular side of 
the receptor. Activated G-protein, interacts with effector molecules such as adenylate 
cyclase and leads to increase in concentration of second messengers such as cAMP. 
Second messenger diffuse to other cellular compartments and interact with other 
downstream effectors, initiating cellular responses. 
Briefly, ligand binding to the extracellular side of receptor initiates the G-protein 
interaction with the intracellular side of the receptor. Nucleotide exchange, specifically 















protein and drives the dissociation of its heterotrimer into Gα and Gβγ subunits (Berg et 
al., 2002). Signaling is terminated by the hydrolysis of GTP by the GTPase activity in the 
α-subunit. The resulting GDP-bound α-subunit re-associates with the βγ-complex to enter 
a new cycle if activated receptors (Wettschureck and Offermanns, 2005). 
 The ligand recognition is by far the most important and crucial part of activating the 
receptor and downstream signaling. As mentioned earlier, the extracellular loops (ECL) 
are the structures that display most heterogeneity and their characteristic folds are 
receptor specific. For example, in the β2 adrenergic receptor (β2AR), ECL2 forms a 
compact helical shape, close to the transmembrane region and allows soluble ligands to 
readily diffuse toward the binding site inside of the receptor (Rosenbaum et al., 2007). In 
contrast, the crystal structure of sphingosine 1 phosphate 1 receptor (S1P1) reveals that 
the ECL2 appears to block the access from the outside and seals off the ligand-binding 
pocket (Hanson et al., 2012). These different binding modes have important implications 
during receptor activation, suggesting that there is no unique switch for all GPCRs. On 
the contrary, by interacting with different regions of the receptors, ligands can modulate 
and/or converge to common active states (Audet and Bouvier, 2012).  
 
Figure 1-9 G-Protein coupled receptor signaling initiation. 
Adenylyl cyclase!
Phospholipase C!




























A stimuli binds to the receptor extracellular portion and causes association of the receptor 
to its cognate G-protein. Nucleotide exchange of GTP for GDP leads to dissociation of 
the heterotrimeric G-protein into an α and a βγ subunits. In turn, the α and the βγ can 
interact with downstream effectors and lead to an increase in concentration of second 
messengers such as cAMP and DAG. Hydrolysis of GTP leads to re-association of the α 
and the βγsubunits into a G-protein heterotrimer and the cycle can be repeated again. 
Activation of the receptor leads to the association of the heterotrimeric G-protein on its 
intracellular side (Figure 1-9). Further, nucleotide exchange decreases the affinity of Gα 
to Gβγ and Gα is freed from the complex and allowed to interact with downstream 
effectors with the canonical effector being adenylyl cyclase. In addition, the βγ-subunit 
can also modulate the activity of other effector proteins (Clapham and Neer, 1997). Some 
of the downstream signaling targets of βγ subunit are isoforms of adenylate cyclase, 
phospholipase C and phosphoinositide-3-kinase (Exton, 1996; Sunahara et al., 1996; 
Vanhaesebroeck et al., 2001). Moreover, most GPCRs are able to activate more than one 
subtype of G-protein which results in the activation of several different pathways both 
through the α and the βγ subunits. However, the interaction between the receptor and the 
G-protein appears to be selective and cell type specific (Wettschureck and Offermanns, 
2005).  
G-proteins composition 
G-proteins are the mediators of signaling from the activated receptors to the downstream 
effectors. The adenylate cyclase is the original model system for studying G-proteins 
whereby it can be either activated or inhibited by different G-proteins. G-proteins consist 
of three subunits: a guanyl nucleotide binding α subunit (39-52kDa), a β subunit (35-
36kDa) and a γ chain (8kDa) (Stryer and Bourne, 1986). G-proteins cycle between GDP-
bound inactive to GTP-bound active state. In the guanyl nucleotide, GDP-bound form, 
the G-protein is a trimer composed of all three α, β and γ subunits. There are many 
subtypes of G-proteins that modulate the functional versatility of GPCRs. The 
heterotrimeric G-proteins are divided into four groups depending on the sequence 
similarities in their Gα subunits (Gαs, Gαi, Gαq and Gα12) (Oldham and Hamm, 2008). 
The α-subunit is a member of the P-loop NTPase and involves guanyl binding (Berg et 
al., 2002). Gα contains a conserved region composed of a GTPase domain, responsible 
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for the GTP hydrolysis and an α-helical domain (Oldham and Hamm, 2008). The GTP-
ase domain is conserved in all G-proteins and is also involved in the binding interface 
with the βγ dimer.  
 
 
Figure 1-10 Heterotrimeric G-protein. 
Gα consist of a Ras domain (yellow) and an α-helical domain (AH) (orange). A 
nucleotide binding pocket is at the interface of the Ras and α-helical domain. Gβ is 
represented in green and the Gγ in purple, wrapping around the β subunit. Both the 
GαRas and the Gγ can mediate interactions with the membrane. 
The β subunit is characterized by a β-propeller fold, composed of seven WD40 sequence 
repeats (Wall et al., 1995). The γ subunit wraps around the β subunit and forms a coiled-
coil at its N-terminus (Figure 1-10). In addition, it bears an isoprenyl post-translational 
modification at its C-terminus, possibly with a farnesyl group that allows for membrane 
interactions (Zhang and Casey, 1996).  
In addition, a combination of 5 different β-subunits and 12 different γ-subunits, can 
compose the βγ-complexes adding even more complexity to GPCRs signal transduction 








Stimulatory Gαs subunit 
The Gαs proteins are ubiquitously expressed and facilitate the activation of adenylyl 
cyclase resulting in the subsequent increase in the second messenger cAMP (Berg et al., 
2002). In turn, the increase of cAMP is able to modulate a variety of cellular processes by 
activating protein kinase A (PKA). This enzyme is composed of two regulatory chains 
(R) and two catalytic chains (C). When cAMP binds to the active chains, the catalytic 
chains are released and are then able to phosphorylate specific serine and threonine 
residues on multiple targets (Berg et al., 2002). The bacterial toxin, Cholera toxin (CTX), 
from Vibrio choleare can ADP ribosylate the Gαs subunit, rendering the G-protein 
catalytically inactive in the GTPase function (Freissmuth and Gilman, 1989). The ADP-
ribosylated Gα subunit is therefore left constitutively active thus constantly stimulating 
the AC, cAMP production and protein kinase A (PKA) activation. Finally, PKA opens 
chloride channels which leads to increased water secretion and can result in diarrhea 
(Gabriel et al., 1994). 
 
Figure 1-11 Effect on G-protein signaling by bacterial toxins. 
Cholera toxin (CTX) ADP-ribosylates the α subunit of Gs, leaving it constitutively 







ribosylates the α subunit of Gi, rendering it inactive and no longer able to inhibit adenylyl 
cyclase. Therefore, both toxin, act through different mechanisms but lead to constitutive 
activation of AC and increase of cAMP concentrations. 
Inhibitory Gαi subunit 
The Gi/Go G-protein family is widely expressed throughout different tissues, where the 
α-subunit is implicated mostly in the inhibition of adenylyl cyclases (Sunahara et al., 
1996). It is also believed that the major signaling processes in the Gi/Go family are 
mediated by the βγ-complexes that are released from the G-protein (Clapham and Neer, 
1997). Studies on this family of G-proteins with Clostridium botulinum (pertussis toxin; 
PTX) show that the PTX can ADP-ribosylate the carboxy terminal of the Gαi, preventing 
the α-subunit from interacting with AC. In turn, AC is constitutively activated and this 
leads to an increase in intracellular concentration of cAMP and activation of potassium 
channels (Figure 1-11). 
Shutting off the signal transduction 
Halting the signal from the activated ligand-receptor-G-protein complex can be 
accomplished in several ways (Figure 1-12). First, the recycling of GTP for GDP 
increases the affinity of the α for the βγ subunits and reforms the G-protein heterotrimer, 
thus turning off the signal. Second, the ligand concentration in the extracellular space 
also plays a role in receptor disensitization. At lower concentrations, the likelihood of a 
7TM receptor rebinding a ligand is smaller and the receptor is predominantly in inactive 
form. G-protein coupled receptor kinases (GRK) can phosphorylate Ser and Thr residues 
on the C-terminal receptor tail. The phosphorylated residues serve as binding sites for β-
arrestins which in turn can prevent the re-association of the G-protein to the receptor and 




Figure 1-12 Regulation of signal transduction of GPCRs by arrestins. 
Arrestins can bind to phosphorylated receptor tails and serve as both regulatory subunits, 
by internalizing the receptor, or signaling subunits. 
It is important to mention that signaling pathways of GPCRs can also be mediated in a G-
protein independent manner, making the regulation and modulation of GPCR signaling 
cascades even more complicated (Azzi et al., 2003; Lefkowitz and Shenoy, 2005). 
1.5 Structural techniques and challenges in studying membrane proteins 
Lipid-protein interactions 
The cell membrane is essential for life as it provides a barrier between the intracellular 
space and the extracellular matrix. Biological processes such as respiration, 
photosynthesis, motility and signal transduction are executed by the interactions between 
membrane proteins and the lipid bilayer. Protein production, purification, stability and 
homogeneity are the major challenges in studying membrane proteins. Membrane 
proteins are embedded in the lipid bilayer and need to be resolubilized by detergent in 














also in their function, folding and even membrane insertion. Understanding the lipid-
protein interactions is crucial to delineate the native environment of membrane proteins 
and their functions (Lee, 2003, 2004). The association between the lipids and the 
membrane proteins is very tight. During protein purification, most of the lipids are lost in 
the process and those that remain are usually those most tightly bound ones. That is why 
in many cases lipids are added during purification in order to keep the proteins stable as 
in the case of human β2-adrenergic G protein-coupled receptor (Cherezov et al., 2007; 
Raunser and Walz, 2009). 
Methods overview to study the structure of membrane proteins 
There are a variety of methods available to study membrane proteins’ structure. All 
methods have their own advantages and disadvantages and the suitability of each depends 
on the identity and the characteristics of the protein of interest. Membrane proteins are 
very challenging targets for structural determination for a variety of reasons. The 
expression, purification, solubilization, inherent flexibility, hydrophobicity and size are 
just of the few of the reasons that make membrane proteins difficult to study. An 
overview of some of the most widely used techniques to study membrane protein 
structure is given below. 
X-ray crystallography 
X-ray crystallography is the primary technique used in protein structure determination 
with the majority of protein structures in the data bank being solved by this method. After 
the protein is purified and crystallized, it is subjected to an intense X-ray beam which is 
diffracted by the proteins in the crystal resulting in a characteristic pattern of spots, 
containing the information about the electron distribution in the protein. X-ray 
crystallography is a very powerful technique that can provide an atomic resolution detail 
for the molecules incorporated into the crystal. Crystallography is an excellent method 
for studying rigid proteins, of modest size, that can form nicely ordered crystals. 
However, flexible proteins, such as the membrane proteins, are more difficult to 
crystallize because they cannot all align in the same orientation to form a crystal. In 
addition, locally flexible regions in a protein that is successfully crystallized can be 
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invisible in the electron density maps because their electron density is smeared over a 
large space. NMR can provide information about the protein in solution and thus also 
provide information for the flexible regions of a protein that are otherwise disordered in 
crystal structures. Recent advances in protein engineering and purification have 
tremendously accelerated x-ray chrystallography as a technique to study membrane 
protein structures. For example, the concept of the lipidic cubic phase (LCP) where 
membrane proteins can freely diffuse in a continuous lipid bilayer for nucleation and 
crystal growth was introduced (Landau and Rosenbusch, 1996). Further, the insertion of 
an N-terminal recombinant lysozyme for the successful crystallization of human β-
adrenergic G-protein coupled receptor complex (Zou et al., 2012)  as well as the 
introduction of a stabilizing nanobody for the crystallization the β2AR-Gαs complex  
(Rasmussen et al., 2011a; Rasmussen et al., 2011b) have transformed the field of 
membrane protein crystallography. 
Nuclear Magnetic Resonance (NMR) 
Both solution and solid state NMR have been used to study membrane proteins’ structure 
and dynamics of membrane proteins. The main advantage of NMR is that the proteins of 
interest can be studied in various environments including different salt concentrations, 
pH, temperature, organic solvents or synthetic micelles. One of the challenges with this 
technique is the requirement for large amounts of very pure protein, usually in the 
milligram scale. As mentioned earlier, the purification and solubilization of membrane 
proteins is difficult and obtaining large quantities of such can be expensive, time-
consuming and sometimes impossible. What distinguishes the solution from the solid-
state methods in NMR is the motional properties of the protein-lipid sample (Montaville 
and Jamin, 2010). Because large protein assemblies (larger than ~ 40kDa) have slower 
molecular tumbling, they are more difficult to study with solution NMR. In contrast, the 
addition of specific stable-isotope to the protein is the limiting factor in solid-state NMR. 
Further, membrane proteins are characterized by high repetitiveness of hydrophobic 
amino acids spanning the membrane, forming primarily α-helices or β-strands. The signal 
overlaps from these structures further complicate the NMR spectra and make the solution 




Electron microscopy has become a very powerful tool for characterizing protein 
structures. There are different methods in electron microscopy used to determine the 
three dimensional shape of proteins. For example, in cryo-EM, the sample is suspended 
in vitreous ice, and in negative stain, the proteins are embedded in heavy metal salt. If the 
protein forms 2D crystals, electron diffraction can be used to generate a 3D density map 
and to solve the structure of the protein (Unwin and Henderson, 1975). Cryo-electron 
microscopy has also made tremendous advances in the study of membrane protein 
structures as a result of instrument and data processing improvements. Generally, it is 
very applicable to supramolecular assemblies that are either too flexible to crystallize for 
X-ray diffraction analysis or too big for NMR to characterize. Thus, the combination of 
cryo-EM with single particle analysis allows for the determination of structures of 
supramolecular machineries in their native environment even in their transient states 
(Zhou, 2011). Viruses are particularly good candidates for cryo-EM because of their large 
size intrinsic symmetry, which allows for signal redundancy and easier averaging in 
single particle analysis. Viral structures have contributed to some of the highest 
resolution structures characterized by single particle analysis, cryo-EM (Cheng et al., 
2010; Zhang et al., 2010). However, as a result of the lower contrast in cryo-EM, proteins 
that are smaller than ~ 200 kDa are difficult to visualize. Therefore, negative staining EM 
may be a more suitable technique to study their structure. 
In negative staining, the sample is embedded and fixed in a solution of a heavy metal salt 
and subsequently dried on the EM grid. The stain embedding provides better contrast in 
comparison with cryo-EM but has its limitations as well. The dehydration of the proteins 
as a result of the negative staining may result in flattening and distortion of the three 
dimensional conformations (Vahedi-Faridi et al., 2012). In addition, this technique can 
provide information only about the surface characteristics of the protein and not their 
internal features. Nevertheless, the negative staining method is an excellent tool to assess 
the quality of purified samples, their homogeneity and purity, a test that is even more 
stringent than SDS gels, gel filtration or even dynamic light scattering. Negative stain 
electron microscopy cannot provide the atomic resolution of X-ray crystallography and 
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NMR. However, it allows us to study the overall shape of large and flexible molecular 
assemblies, in their native state. 
Applying Negative Stain EM for Structural Analysis of Proteins 
Image Formation 
After emitted from the source, the electron beam is deflected through a set of condenser 
lenses ensuring that the beam is parallel (Figure 1-13a). Then, the electron beam passes 
through the specimen by which the electrons are either scattered or not (Figure 1-13b). 
The inelastically scattered electrons provide the background noise of an image. The areas 
where the electrons are scattered, are in the range of grey and where the electron are 
unscattered the image is brighter (Frank, 2006; Williams and Carter, 1996). In contrast, in 
the regions where the electrons do not pass through the sample the image appears dark. 
However, in negative staining, as the name suggests, things are reversed. Background 
areas, covered in stain appear dark, while proteins appear brighter and are stain excluded. 
The scattered electrons interact further with the magnetic field of the objective, followed 
by an intermediate and projector lenses which in turn form an image (Figure 1-13). The 
image is then viewed on a fluorescent screen or can be recorded by a charge-coupled 
device (CCD) camera or conventional film (Williams and Carter, 1996). Because no lens 
is perfect the achievable resolution of an image is partly depended on the lens 
aberrations. There are three main sources of aberrations - spherical aberration, chromatic 
aberration and astigmatism. In the case of spherical aberration, the peripheral electrons 
are deflected more than the electrons closer to the center. This aberration can be 
improved with thinner samples. 
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Figure 1-13 TEM lens organization and electron path through the sample. 
a, Lens organization in the column of the EM. Red arrows represent the electron path. b, 
Electron diffraction path through the sample.  
Chromatic aberration is related to the energy of the electrons which emerge from the gun 
with different energies and are subsequently bent by the objective lens to different 
degrees with the ones with less energy being bent more. This is the aberration that most 
significantly defines the performance of the objective lens. Both types of aberrations 
result in a disk rather than a point where all the rays converge which makes the image 
blurred and may reduce contrast. The astigmatism is caused by the inherent property of 
the electromagnetic lens lacking a perfect cylindrical symmetry. Thus, this aberration 
affects the ability to focus an image but could be easily corrected by the stigmators 
(Frank, 2006). In addition, the resolution limit is also dependent on the nature of the 
biological sample. For example, because higher electron dose could damage biological 
samples, obtaining high sample contrast and better resolution is dependent on the dose 
rate. Furthermore, sample heterogeneity can also lead to lower resolution structures.  
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Single Particle Analysis 
Single particle analysis aims to determine the structure of macromolecules from images 
of individual particles, termed single particle projections. In negative staining the 
particles are fixed on a carbon support, embedded in heavy metal salt. Furthermore, based 
on their shape and charge they can assume preferred orientation on the carbon support. 
The single particle analysis method is a compilation of a few computerized image 
processing techniques used to analyze the images from TEM. Generally, the micrographs 
from the electron microscope are characterized by a very low signal-to-noise ratio. 
Therefore, the integral part in image processing is to improve signal-to-noise ratio by 
averaging large number of particle projections. With single particle analysis, the structure 
of a macromolecular protein complex can be determined from the images of individual 
particles (Frank, 2006). The homogeneity of the protein sample is critical in single 
particle analysis although, samples with conformational heterogeneity can also be 
analyzed.  
Reference-free alignment and classification 
The purpose of the alignment of several images is to increase the signal-to-noise ratio. 
After the particles have been boxed out, the averaging is carried out through translational 
and rotational alignments of the particle projections using reference-free procedures 
(Frank, 2006). In this method, multiple views from particles of a particular data set are 
separated into classes by comparatively aligning the particle projections to randomly 
chosen particles from the same data set. In essence, the randomly chosen initial 
projections are used as models and the remaining particles are grouped with them based 
on cross-correlation values. All the particles in each group are averaged out and the 
resulting class average is then used as a new reference. The alignment procedure is 
performed iteratively with multiple cycles until class averages are produced with no 
further change in the overall image shifts and rotations (Ohi et al., 2004). Each average 
contains similar particle projections, creating improved signal-to-noise ratio, and allows 
for clearer visualization of the protein’s features. In addition, the number of required 
classes can be chosen based on the heterogeneity of the sample. That is why initially, it is 
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good to start with few classifications containing different number of classes. A good 
indication would be if there are more output averages that represent a significant number 
of projection structures and the raw particle projections resemble their class averages. 
Further, unique classes can be selected from the classification and used for subsequent 
classifications to improve the model and enrich the population of particles in the specific 
group. There are few software packages capable of performing image alignment, 
classification and also multireference alignment such as IMAGIC (van Heel et al., 1996), 
SPIDER (Frank et al., 1996) and EMAN (Ludtke et al., 1999). 
Contrast transfer function 
The electron microscope distorts the structural information from the protein sample by 
changing the amplitudes and phases of the recorded electron waves. These artifacts are 
dependent on the microscope’s objective lens spherical aberration coefficient, the voltage 
and defocus values used as well as the spatial frequency. The contrast transfer function 
(CTF) defines the transfer of contrast from the sample to an image by defining the 
relationship between the Fourier transform of an object’s image and the Fourier transform 
of an object’s Coulombic potential multiplied by the contrast transfer function (Wade, 
1992). The CTF is an oscillating function with amplitude that can be plotted against the 
resolution in inverse angstroms (Figure 1-14). The CTF oscillates from positive contrast 
transfer to negative contrast transfer as it passes through zero, where the information 




Figure 1-14 Contrast transfer function (CTF) curve. 
This is an example of a contrast transfer function curve for a TEM operating at 200 kV, 
with Cs=2 and for a defocus value of 1000 nm. The signal amplitude is plotted against 
the resolution in inverse angstroms (x-axis). The experimental contrast transfer curve is 
in black and oscillates from positive to negative values, while the signal gradually with 
increasing resolution (Courtesy of Georgios Skiniotis). 
Since the exact location of the zero crossings depends on the defocus values, by 
collecting images at different defoci, the resolution limit of a 3D reconstruction could be 
improved. Another way to correct for the lost image information is to obtain a constant 
positive phase values by inverting the negative values of the micrograph’s CTF. The so-
called “phase-flipping” can be performed by determining the values of the parameters, 
contributing to the shape of the CTF of each micrograph and using these values to flip the 
negative regions of the curve to positive ones (Zhu et al., 1997).  
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Three dimensional reconstruction 
Among the mathematical operations to be carried out in the computer are alignment, 
determination of particle orientation (by random conical technique, common lines or 
reference to an existing density map), classification, reconstruction and correction of the 
contrast transfer function (CTF). A three dimensional reconstruction from the protein’s 
2D projections is achieved with several algorithms and approximations where the 2D 
projections along a 3D object contain sufficient information to restore the original object. 
For this purpose the orientation angles of each projection must be known. As the protein 
particles interact with the carbon support they form different projections which must fully 
fill Fourier space from all directions (Llorca, 2005). Therefore, the requirement to resolve 
the 3D structure of a protein is to establish the orientation of each projection image with 
respect to some reference coordinates. The orientation can be characterized by the 
projection’s Euler angles which are directional angles used to define the position of a 
particle around a common center. For this procedure, the data set needs to be of a 
sufficient size as well as to contain particles in the same conformation and different 
orientations on the carbon support. In cases when the protein falls on the grid in a 
preferred orientation or because it has an inherent conformational flexibility, different 
views cannot be unambiguously assigned to a specific conformation. The random conical 
tilt procedure in such situations can provide a solution to this and generate a 3D volume 
for each type of view (Llorca, 2005; Radermacher and Ruiz, 2006). 
Random conical tilt reconstruction 
The Random Conical Tilt (RCT) method is used to generate a reconstruction of a three 
dimensional image, taking advantage of the preferred orientation of the specimen with 
respect to the plane of the grid (Radermacher et al., 1987). In this approach, one 
micrograph is taken at 0° and another at a high tilt angle of 60° (could also be 50°-70°) 
degrees) (Figure 1-15a). The two images are digitized and put side put side-by-side where 
the same particles at different angles are selected (Figure 1-15b). The images of the 
untilted particles are then correlated to their tilted counterparts by the direction of the tilt 
axis and the tilt angles. After the untilted particles have been aligned and classified, the 
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angles and shifts are also applied to the corresponding particles from the tilted images. 
Thus, their orientations in space are determined (Figure 1-15c). The projections of the 
tilted particles will form a cone with a fixed tilt angle of 60° degrees and a random 
azymuthal angle series that can be extracted for the untilted particles and used for the 
reconstruction. By back-projecting the tilted particle projections, the initial model can be 
reconstructed (Figure 1-15d). One of the advantages of this method is that no initial 
model is needed and thus it can be used to generate one for subsequent reconstructions 
from negative stain and/or cryo EM. 
Angular refinement 
Angular refinement is an iterative process used to increase the visible details of the model 
obtained in the previous step by better defining the angular position of each experimental 
projection. In this method, the initial reconstruction serves as an initial reference structure 
from which two-dimensional projections are computed and then compared to the 
experimental projections, yielding refined angles. From the refined angles a new 
reconstruction is obtained which is consequently used as a reference for the next cycle. 
The process is repeated iteratively until no further improvement in the 3D model is 
observed and the orientation angles have been stabilized. (Fuller et al., 1996; Zhu et al., 
1997). A new reconstruction is calculated based on these parameters and it is used as an 




Figure 1-15 Random Conical Tilt.  
a., Red arrows show the electron path through the sample imaged at 0° and 60° degrees. 
b., Micrographs containing multiple single particle projections from the 0° and 60° 
degree are collected and the individual particles and picked and excised. c., Orientational 











parameters of tilted particles are assigned based on their relationship to the untilted 
particles. d., After back-projecting the different views, the original image of the specimen 
can be restored. 
This process is repeated until the Fourier shell correlation (FSC) curve is converged. 
Figure 1-16 is a sample angular distribution plot of a 3D reconstruction of the single 
chain LepR, where the particles are spread in angular space around a reference model. 
Each mark inside the circle indicates the position of a matched projection with the ones 
near the center corresponding to the untilted particles and the ones surrounding the ring to 
the tilted particles. The more dots, the more representative views of the protein have been 
imaged and ideally the whole space should be filled. 
  
Figure 1-16 Angular plot of single chain extracellular LepR. 
The graph represents the angular distribution of particles, relative to a reference volume 
of the single chain LepR. Each dot marks a reference projection that has a matched 
experimental particle. 
In addition, when the particles have preferred orientation their corresponding 2D 
averages will contain more particles. This in turn will increase signal-to-noise ratio for a 
particular class, potentially increasing the resolution in the direction of space 
corresponding to the preferred orientations. The final resolution of the 3D reconstruction 
is calculated when the data set is split into two randomly selected subpopulations and two 
corresponding 3D maps are calculated. The Fourier Shell Correlation curve (FSC) is 
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calculated between the two volumes (a comparison in Fourier space) and the 
reconstruction’s resolution limit is determined at the FSC value of 0.5 (FSC=0.5). 
1.6 The leptin receptor system - a brief historical perspective 
The first documented case of genetically obese animals, the ob/ob mice, dates back to the 
1950s (Ingalls et al., 1950). However, it was not until later that another group discovered 
a nonsense mutation in the ob/ob mice (Zhang et al., 1994). The gene bearing the 
nonsense mutation makes the 16 kDa leptin hormone, normally expressed in the white 
adipose tissue. The mutation causes a truncation in the hormone making it unable to be 
secreted and causing extreme obesity in the mice (Zhang et al., 1994). Interestingly, the 
authors also reported that the expression of the ob gene in mice is greatly enhanced 
compared to their wild-type counterparts (Zhang et al., 1994). To identify the high 
affinity binding site of leptin or in other words the leptin receptor (LepR), Tartaglia and 
colleagues used a radioactively labeled leptin in mouse tissues and performed binding 
assays to identify the major sites of leptin binding. After constructing a cDNA library, the 
authors were able to isolate and clone the LepR which they characterized as a single pass 
membrane receptor similar to glycoprotein 130 (gp130), Interleukin-6 receptor (IL-6R), 
granulocyte colony stimulating factor receptor (GCSF-R) and leukemia inhibitory factor 
receptor (LIF-R) (Tartaglia et al., 1995). 
 Leptin  
The hormone leptin belongs to the hematopoietin family of cytokines because of its 
shared structural homology to interleukin-6 (IL-6), leukemia inhibitory factor (LIF) and 
cilliary neutrophic factor (CNTF), to name a few (Zhang et al., 1994). Because the native 
leptin peptide is very prone to aggregation, its poor solubility proved its crystallization to 
be very challenging. Systematic site-directed mutagenesis during the crystallographic 
trials led to the discovery of a single amino acid substitution at its surface having a 
dramatic effect on its solubilization. The yielded analog, leptin-E100, bearing a single 
amino acid substitution of Glu for Trp at position 100, finally allowed its crystallization 




The hormone leptin and the leptin receptor (LepR) 
Structurally, leptin bears striking similarity to other four-helical bundled cytokines such 
as LIF (Robinson et al., 1994) and G-CSF (Hill et al., 1993). In addition to many 
similarities, the structure of leptin also has a few notable differences from other 
cytokines. For example, G-CSF and LIF have well pronounced kinks in the middle of 
helix A and D, respectively, in order to maximize helix contacts in these structures. 
Leptin, on the other hand, has only a small kink at the end of helix D (Zhang et al., 2005). 
Like other class I cytokines, leptin possesses three binding epitopes at sites I, II and III 
which can be potentially engaged with receptor interactions and activation (Bravo and 
Heath, 2000; Iserentant et al., 2005). Peelman and colleagues showed that epitope II of 
leptin constitutes the primary binding site to the receptor (Peelman et al., 2004). 
However, the existence of the two more putative binding epitopes has led to substantial 
controversy in terms of the formation of the leptin/LepR signaling complex (Couturier 
and Jockers, 2003; Mistrik et al., 2004; Peelman et al., 2006). 
 
Figure 1-17 Ribbon diagram of the crystal structure of leptin.  
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A four-helical bundle conformation of human leptin. Blue arrows point to putative 
binding epitopes based on structural similarities to other four-helical bundle cytokines.  
 
LepR belongs to class I cytokine receptors which includes glycoprotein 130 (gp130), the 
LIF receptor (LIF-R), the CNTF receptor (CNTF-R), the granulocyte colony stimulating 
factor receptor (GCSF-R), and others (Tartaglia et al., 1995) (Wang et al., 2009). 
Receptors from this class are characterized with conserved signature domain organization 
at their extracellular end. LepR has seven domains grouped into modules on the 
extracellular side of the membrane. Along with oncostatin M receptor (OSM-R) and LIF-
R, LEP-R is an unusual class I receptor since it contains not one, but two CHR modules. 
The N-terminal CHR1 and the C-terminal CHR2 are membrane-distal and separated by 
an immunoglobulin-like domain (IgD). Each CHR module consists of two domains with 
a characteristic fibronectin type III (FnIII) fold that contain the classical motif for 
cytokine binding (Wang et al., 2009). In addition, both CHR modules represent potential 
ligand binding sites, however, only CHR2 has been shown to be required for leptin 
binding (Fong et al., 1998; Iserentant et al., 2005; Peelman et al., 2004). Furthermore, 
unlike LIF-R and gp130, LEP-R possesses two, rather than three, FNIII membrane-
proximal domains. Although the IgD (D3) and the two membrane-proximal FnIII 
domains are not prerequisites for high-affinity leptin binding, they have been shown to be 
essential for LEP-R activation (Zabeau et al., 2005; Zabeau et al., 2004).  
To this end, there are at least five known isoforms of LepR (a-f) produced by alternative 
splicing of the db gene (Lee et al., 1996; Tartaglia et al., 1995). All isoforms are identical 
at their extracellular region but differ in length at their C-terminal tails. The shortest, 
isoform e, is truncated proximally to the membrane-spanning domain and functions as a 
soluble circulating leptin-binding protein. In addition, the longest isoform b is the only 
one having signaling capabilities (Friedman, 1998). LepR is primarily expressed in the 
hypothalamus, at the areas involved in the regulation of energy balance such as the 
arcuate and ventromedial nuclei (Elmquist et al., 1998). Therefore, leptin’s ability to 
regulate food intake can be primarily attributed to its actions in the hypothalamus. 
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Class I cytokine receptors are not kinases themselves. Instead, they rely on constitutively 
bound Janus kinases (JAKs), at their intracellular domains (ICD) for activation. There are 
two highly conserved motifs on the LepR ICD, termed box 1 and box 2 which are 
required for Jak2 binding and activation (Kloek et al., 2002). A few studies have 
suggested that ligand-binding on the extracellular portion of the receptor is a prerequisite 
for Jak2 signal instigation by way of stabilizing the transmembrane region in a certain 
conformation and thus favorably orienting the JAK2s toward each other (Couturier and 
Jockers, 2003; Murray, 2007).  
Signal transduction pathways activated by leptin 
Ligand-binding to the leptin receptor can lead to the activation of numerous downstream 
signaling pathways. Once activated, JAK2 phosphorylates multiple tyrosine residues on 
the intracellular receptor tail which serve as binding site for downstream signaling 
effectors. Some of the pathways that lepin activates include JAK/STAT, SHP-2, MAPK, 
phosphatidylinositol 3 kinase (PI3K and AMP-activated protein kinase (AMPK) (Zhang 
et al., 2005). Leptin signaling through the JAK/STAT pathway has been well studied. 
STAT3 binds on the receptor tail upon phosphorylation of Tyrosine1138 which results in 
JAK2-mediated phosphorylation and subsequent release into the cytoplasm, dimerization 
and translocation to the nucleus. In the nucleus, the STAT dimer binds DNA and 
instigates transcription of genes predominantly involved in expression of numerous 
neuropeptides involved in feeding and regulating body energy balance (Zhang et al., 
2005). Activation of LepR also induces the expression of SOCS3 in the hypothalamic 
area by direct binding of STAT3 to the response element (Bjorbaek et al., 1998). SOCS3 
is an SH2 domain-containing protein, capable of binding phosphorylated Tyr985 on 
JAK2 inhibiting JAK2 activity and abolishing LepR signaling (Bjorbaek et al., 1999). In 
addition, leptin-mediated MAP kinase activation is promoted through SH2-containing 
phosphatase 2 (SHP-2) which binds to the phosphorylated LepR and simultaneously 
inhibits STAT3 activation (Banks et al., 2000). Moreover, there is a strong correlation 
between leptin and insulin signaling pathways. It has been suggested that the 
hypothalamic leptin receptor signaling couples to the intracellular insulin-receptor 
substrate (IRS)-PI3K pathway via JAK2-mediated phosphorylation of IRS and Grb-2 
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protein (Villanueva and Myers, 2008). Also, it has been postulated that leptin can 
regulated lipid metabolism through fatty acid oxidation by activating AMPK (Minokoshi 
et al., 2002). 
Biomedical significance of leptin/LepR system 
Leptin is a pleiotropic adipokine and its receptors are located not only in the 
hypothalamus but also in peripheral tissues such as monocytes, lymphocytes, vascular 
tissue, pancreas, skeletal muscle and myocardium (Margetic et al., 2002). Given the 
broad expression of the receptors and plethora of pathways activated upon leptin 
signaling, it is not surprising that perturbations in the leptin system lead to serious 
illnesses. After the discovery of leptin and its successful crystallization, scientists thought 
that the solution for treating obesity would be a straightforward one. However, the initial 
recombinant leptin treatment for obesity did not yield the expected results. Leptin 
administration was shown to successfully suppress appetite and reduce excessive fat in 
obese humans with genetic leptin deficiency (Farooqi et al., 2002). In contrast, leptin 
therapy in the majority of human obese patients only resulted in modest weight reduction 
(Mantzoros and Flier, 2000). Interestingly, most obese individuals exhibit elevated 
circulating leptin concentrations, indicating leptin resistance rather than deficiency 
(Considine et al., 1996).  
Lipodystrophy is another rare disease characterized by low leptin levels and associated 
with insulin resistance, hyperglycemia, hyperinsulinemia and hepatic steatosis (Garg, 
2000). Treating lipodystrophic patients with leptin leads to an improvement in their 
glycemic control and decreases triglyceride levels. In addition, leptin deficiency 
contributes to insulin resistance and other abnormalities associated with severe 
lipodystrophy (Oral et al., 2002). Hypothalamic amenorrhea is yet another disease 
associated with leptin deficiency (Bluher and Mantzoros, 2007). Recombinant leptin 
therapy in these patients has been shown to improve the gonadal function associated with 
nutritional calorie deficiency (Welt et al., 2004). However, the development of better 
leptin analogs for long-term treatment is needed because of leptin-related weight loss in 
those patients, already underweight. Obesity also increases the risk of cardiovascular 
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disease and the elevated leptin levels in such individuals are found to be correlated with 
hypertension and atherosclerosis, stroke and inflammation (Beltowski, 2006; Sweeney, 
2010). 
The above mentioned clinically-related diseases implicated by leptin do not cover by far 
all potential clinical application of leptin-based therapies. Therefore, understanding the 
molecular mechanisms of leptin signaling and resistance is crucial to combat not just 
obesity but all pathways affected by defective leptin signaling in order to develop 
effective therapeutics. 
Part of the work in this thesis is concerned with investigating the leptin/leptin receptor 
signaling complex and aims to uncover valuable insights of the mechanism of activation 
and understand better this pleiotropic pharmacological target.   
1.7 The Opioid Receptor System 
Introduction to opiates and their receptors 
For centuries, opium and its derivatives have been utilized in medicine for treatment of 
chronic pain as well as “recreationally” as euphoriant agents. Opium is an extract of the 
poppy plant Papaver Somniferum. Friedrich Serturner was the first to identify morphine 
as the active ingredient. However, it was not until over a hundred years later when the 
actions of morphine were demonstrated at the receptor level (Pert and Snyder, 1973). 
Opiate receptors are of fundamental physiological importance because they mediate 
responses for pain, sedation and euphoria (Waldhoer et al., 2004). Opioid drugs such as 
morphine and codeine are invaluable pain killers and sedatives but their addictive nature 
limits their clinical usage. The opioid receptors therefore are important structural targets 
to design new drugs exerting beneficial actions and lacking the side effects (Hughes and 
Kosterlitz, 1983; Waldhoer et al., 2004). 
Opioid receptors can be activated by a variety of ligands either produced by the body 
(e.g. endorphins), found in nature (e.g. morphine) or synthetically made (e.g. heroin). 
Various glands throughout the body, such as the pituitary and the adrenal glands as well 
as the central nervous system (CNS) are responsible for production of endogenous opioid 
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peptides. Endogenous opioids are secreted as hormones or neurotransmitters in the 
circulation, travel to target organs and induce responses (Janecka et al., 2004). 
Endogenous opiate peptides can also serve as neuromodulators when produced by nerve 
cells and produce responses in the brain and the spinal cord. By mediating their actions 
on the CNS and in the circulation, endogenous peptides serve a broad range of 
physiological roles. The opioid receptors are also activated by exogenous non-peptide 
molecules termed alkaloids or opiate drugs such as morphine (Kieffer, 1995). These 
drugs can produce not only strong analgesic effects but also very addictive actions by 
mimicking the actions of the endogenous peptides. In addition, adverse side effects of 
opiate drugs could be attributed to their interference with the tightly regulated 
endogenous opioid system. 
Classification of opioid receptors 
Even before their biochemical identification, the notion of receptor subtypes has been 
suggested by classical pharmacological studies. To this end, there are four opioid 
receptors cloned and they are named after the pharmacological profile of the compounds 
used to identify them - MOR (µ = mu for morphine), KOR (κ = kappa for 
ketocyclazocine), DOR (δ = delta for deferens) and the NOR (nociceptin-orpharin) 
receptors (Waldhoer et al., 2004). It is suggested, however, that there may be additional 
opioid receptor subtypes resulting from posttranslational modification, alternative mRNA 
splicing, tissue distribution and alternative protein scaffolding (Jordan and Devi, 1999; 
Pasternak, 2001). Opioid receptors are coupled to pertussis-toxin-sensitive inhibitory G-
proteins termed Gi/o (Yaksh, 1997). The opioid signals are efficiently blocked by 
pertussis toxin (PTX), a bacterial toxin by Bordetella pertussis which ADP-rybosylates 
the α subunit thus inactivating Gi heterotrimer and preventing the receptor from 
signaling. In general, the Gi action is mediated through blocking the activity of adenylyl 
cylase which in turn reduces cAMP and leads to multiple actions, including modulation 
of sodium channel activity (Law et al., 2000). In addition, the G-proteins can also act by 
stimulating the potassium channels and increasing calcium levels (North et al., 1987) (Jin 
et al., 1992). Interestingly, G-proteins have also been shown to regulate mitogen-
activated protein kinase (MAPK) activity (Standifer and Pasternak, 1997). Understanding 
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the opioid receptors mediated signal transduction is crucial to understanding the 
regulatory mechanisms of their effectors. An important class of proteins that serve as 
GTPase activating proteins by facilitating the hydrolysis of GTP to GDP are regulators of 
G-proteins (RGS). The nucleotide hydrolysis facilitates the G-protein subunits re-
association and signal termination and they have been implicated in opioid tolerance 
(Garzon et al., 2001). Another mode of regulation of GPCR signaling is through β-
arrestins. Upon agonist stimulation of GPCRs, the G-protein receptor kinases (GRKs) 
phosphorylate the receptor which in turn leads to the recruitment of β-arrestins. These 
proteins promote the dissociation of G-proteins from the receptor and terminate signaling. 
In addition, G-proteins are also capable of facilitating the internalization of inactivated 
receptors to promote recycling or even degradation (Raehal and Bohn, 2005). 
Interestingly, β-arrestins have been shown to also have signaling roles by associating 
with additional scaffolding proteins and thus influencing overall receptor responsiveness 
(Shukla et al., 2011). 
The µ-opioid receptor (MOR) 
MOR is a subtype of opioid receptors class of GPCRs.  MORs are encoded by the MOR-
1 gene and they bind morphine most tightly compared to DORs and KORs. Studies in 
mice have shown that opioid alkaloids target primarily µ-opioid receptors to exert the 
effects of analgesia, euphoria, sedation, respiratory depression and cough suppression and 
even constipation as a peripheral effect (Katzung, 2009; Matthes et al., 1996). Because 
the opioid drugs are highly addictive, their clinical efficacy is limited by the development 
of tolerance and dependence. Activation of MOR can be attributed to both beneficial and 
adverse effects likely mediated by different downstream signaling and regulatory 
pathways.  
To signal, µ-OR couples to Gi/Go subunit which is responsible for its analgesic effects 
(Raffa et al., 1994). Several chimeric and mutagenesis approaches have identified 
functional residues in the receptor, responsible for ligand-binding on the N-terminus and 
G-protein (Pan and Pasternak, 2011). As a member of the GPCR family, the MOR also 
utilizes a GTP/GDP exchange within the heterotrimeric G-protein to catalyze signaling. 
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Activation of the receptor is through its interaction with G-proteins which induces the 
release of GDP from the α-subunit of the G-protein. This allows GTP to bind and results 
in the dissociation of the heterotrimeric G-protein into α and βγ signaling subunits. The α 
subunit has an inherent GTPase activity, which hydrolyzes the bound GTP to GDP 
resulting in the recycling of the heterotrimeric G-protein into its inactive state thereby 
affecting the signal potency and efficacy. 
The crystal structure of the MOR has been determined in the presence of bound 
antagonist, morphinan, but in the absence of associated G-protein (Manglik et al., 2012). 
Opioid receptors are similar to other GPCRs in their overall helical organization. Further, 
recent crystal structures have revealed a remarkably deep ligand-binding pocket in 
GPCRs. In the crystal structure of MOR, however, the bound antagonist is largely 
exposed to the extracellular surface, suggesting why the half-life of some opioid ligands, 
such as heroin, is short. Additionally, the receptor is crystallized as a twofold 
symmetrical dimer with a significantly large contact between individual protomers which 
suggests that this could serve as stabilization mechanism in vivo (Manglik et al., 2012). 
Despite the plethora of biochemical and recently structural information about the MORs, 
their mechanism of activation is still poorly understood. 
Insights from recent structural studies 
Recently the crystal structures of MOR, DOR and KOR have been reported (Granier et 
al., 2012; Manglik et al., 2012; Wu et al., 2012). Most likely their crystal structures 
represent an inactive state because they were crystallized in the presence of antagonist 
and without a bound G-protein. Nevertheless, these structures provide detailed 
information about ligand-binding specificity and an insight into an activation mechanism 
by a conformational rearrangement of the transmembrane helices. 
Recent studies of β2AR in complex with its G-protein have also begun to reveal some 
insight into its activation mechanism. Specifically, it has been suggested that the 
conformational changes in the receptor are coupled to conformational changes in the G-
protein, resulting in the movement of the N-terminal α-helical domain which in turn 
opens the nucleotide binding pocket (Chung et al., 2011; Rasmussen et al., 2011b; 
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Westfield et al., 2011). It is supposedly logical to think that the MOR involves a similar 
activation mechanism, although, the presence of the characteristically deep and solvent 
exposed binding pocket could potentially dictate a different mechanism. Thus, the precise 
structural basis for the MOR activation and specifically, how upon ligand-binding the 
structural information is transferred to the G-protein and to downstream effectors, 
remains to be elucidated. Also, the ultimate goal of the opioid research is to determine the 
optimal ligand-receptor complex profiles that infer maximal clinical efficacy with 
minimal side effects.  
The second part of my thesis work is concerned with analyzing the MOR-Gi complex 
with negative stain electron microscopy and comparing its overall domain organization to 
that of the β2AR-Gαs complex. In addition, one of the long-term goals of this work is to 
discover stabilizing nucleotides and/or nanobodies that will aid in the crystallization of 
the complex. Ultimately, the EM studies of the MOR-Gi complex would reveal a 
common mechanism of activation of the intracellularly bound G-proteins by a way of 
flexing and extending the AH domain of the Gα subunit. 
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Chapter 2  Ligand induced architecture of the leptin receptor signaling complex 
2.1 Abstract  
Despite the crucial impact of leptin signaling on metabolism and body weight, little is 
known about the structure of the primary transducer in this pathway, the liganded leptin 
receptor (LEP-R) complex. Here we applied single-particle electron microscopy (EM) to 
characterize the architecture of the extracellular region of LEP-R alone and in complex 
with leptin. We show that unliganded LEP-R displays significant flexibility in a hinge 
region within the cytokine homology region 2 (CHR2) that is connected to rigid 
membrane-proximal FnIII domains. Examination of liganded LEP-R complexes reveals 
that leptin binds to CHR2 in order to restrict the flexible hinge and the disposition of the 
FnIII ‘legs’. Through a separate interaction, leptin engages the Ig-like domain of a second 
liganded LEP-R, resulting in the formation of a quaternary signaling complex. We 
propose that the membrane proximal domain rigidification in the context of a liganded 
cytokine receptor dimer is a key mechanism for the transactivation of dimeric Janus 
kinases (Jaks) bound at the intracellular receptor region. 
2.2 Introduction  
Cytokines are secreted signaling molecules that mediate crucial cellular responses 
through binding to their respective cell surface receptors (Gainsford et al., 1996; Hirahara 
et al., 2010; Li et al., 2008). Leptin, a class I cytokine, plays a key role in the regulation 
of energy homeostasis and body weight. Leptin is secreted from adipose tissue at levels 
that are proportional to body fat content (Considine et al., 1996), and after crossing the 
blood-brain barrier it engages the leptin receptor (LEP-R) in the central nervous system 
in order to modulate both food intake and energy expenditure (Bates et al., 2003; Halaas 
et al., 1995; Morton et al., 2005). Based on controlling homeostasis and growth, leptin 
signaling also regulates the endocrine and immune systems, affecting diverse processes 
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such as glucose level regulation, reproduction, bone formation and wound healing 
(Ahima et al., 1996; Lord et al., 1998; Peelman et al., 2006a).  
Leptin adopts a four-helix bundle structure, sharing structural homology to several helical 
cytokines of the hematopoietin family, such as interleukin-6 (IL-6), leukemia inhibitory 
factor (LIF), and ciliary neurotrophic factor (CNTF) (Zhang et al., 1997). Based on 
structural analyses and comparisons with homologous cytokines, leptin possesses three 
binding epitopes (sites I, II and III) that can be potentially employed for receptor 
engagement and activation (Bravo and Heath, 2000; Iserentant et al., 2005). Earlier 
biochemical studies suggested that epitope II constitutes the primary binding site of leptin 
to LEP-R (Peelman et al., 2004). However, the roles of the remaining epitopes in forming 
the leptin/LEP-R complex have been a matter of debate, leading to different models for 
the signaling assembly (Couturier and Jockers, 2003; Mistrik et al., 2004; Peelman et al., 
2006b).  
 
Figure 2-1 Crystal structure of some class I cytokines 
Top row, left to right – side views crystal structures of leptin, IL-6, CNTF and LIF; 




The leptin receptor exists in at least five isoforms (LEP-Ra-e) differing in the length of 
their C-terminal tails, but only the long isoform b has demonstrated full intracellular 
signaling capabilities (Friedman, 1998; Lee et al., 1996). LEP-R belongs to the class I 
cytokine receptor family, which includes glycoprotein 130 (gp130), the LIF receptor 
(LIF-R), the CNTF receptor (CNTF-R), the granulocyte colony stimulating factor 
receptor (GCSF-R), and others (Baumann et al., 1996; Tartaglia et al., 1995; Wang et al., 
2009). Class I cytokine receptors do not possess intrinsic kinase activity, but rely on 
activating Janus kinases (Jaks) that are constitutively bound to the receptor intracellular 
domains (ICDs). The ICD of LEP-R, which consists of approximately 300 amino acid 
residues (b-isoform), includes two highly conserved membrane-proximal motifs, termed 
box1 and box2, that are critical for Jak2 binding and activation (Kloek et al., 2002). As 
has been proposed with other cytokine receptors, leptin binding on the extracellular 
portion of LEP-R presumably stabilizes the trans-membrane receptor α-helices in a 
conformation that favors Jak2 trans-phosphorylation and subsequent instigation of 
downstream signaling (Couturier and Jockers, 2003; Murray, 2007).  
The signature module of class I cytokine receptors is the so-called cytokine homology 
region (CHR) in the extracellular portion. The CHR consists of two domains with a 
characteristic fibronectin type III (FnIII) fold that contain the classical motif for cytokine 
binding (Wang et al., 2009). Along with oncostatin M receptor (OSM-R) and LIF-R, 
LEP-R is an unusual class I receptor since it contains not one, but two CHR modules. The 
N-terminal CHR1 and the C-terminal CHR2 are membrane-distal and separated by an 
immunoglobulin-like domain (IgD). Both CHR modules represent potential ligand 
binding sites, however, only CHR2 has been shown to be required for leptin binding 
(Fong et al., 1998; Iserentant et al., 2005; Peelman et al., 2004). Furthermore, unlike LIF-
R and gp130, LEP-R possesses two, rather than three, FnIII membrane-proximal 
domains. Although the IgD (D3) and the two membrane-proximal FnIII domains are not 
prerequisites for high-affinity leptin binding, they have been shown to be essential for 




Figure 2-2 Domain organization in class I cytokine receptors. 
Members of class I cytokine receptors have similar domain organization at their 
extracellular regions. The domains consist of an array of fibronectin II fold structures, 
grouped into modules. Cytokine homology region (CHR) and Immunoglobulin (Ig) 
domain play role in ligand binding. Intracellular short tails contain conserved motifs Box 
1 and 2 that are required to Janus kinase binding. 
Earlier studies on cytokine receptor complexes, such as gp130/IL-6/IL6-Rα (Boulanger 
et al., 2003a; Skiniotis et al., 2005), gp130/LIF-R/CNTF/CNTF-Rα (Skiniotis et al., 
2008), and the granulocyte colony-stimulating factor (GSCF) with its receptor GSCF-R 
(Tamada et al., 2006), have provided a wealth of information on the structural 
organization of these important signaling assemblies, shedding light on common 
principles of complex formation. Very recently, the crystal structure of human LEP-R 
CHR2 in complex with a Fab fragment from a leptin blocking monoclonal antibody 
provided insights into the mechanism of antagonism and potential modes of leptin 
binding to this region (Carpenter et al., 2012). However, owing to the existence of the 
three conserved epitopes on leptin, the structure of the activated signaling leptin/LEP-R 
complex has been a matter of debate, with the two main models proposing either a 2:2 or 
 
62 
a 2:4 stoichiometry between leptin and LEP-R (Figure 2-3) (Couturier and Jockers, 2003; 
Mistrik et al., 2004; Peelman et al., 2006b). 
 
Figure 2-3 Hexameric homology model of the leptin/LEP-R complex. 
The model is based on the 3 leptin binding epitopes (from Peelman et al.,2006b). the 
CHR2 domain form one receptor chain engages epitope II of one leptin molecule which 
the Ig domain of another LepR engages epitope III of the same leptin molecule. Epitope I 
of leptin is potentially involved in interaction with an additional LepR chain, forming a 
4:2 signaling complex. 
Given the lack of structural information on LEP-R and the controversy regarding its 
arrangement when bound to leptin, we used single-particle electron microscopy (EM) to 
visualize the extracellular portion of LEP-R alone and in complex with the cytokine. This 
approach allowed us to elucidate the architecture the leptin/LEP-R complex, and to 
obtain valuable insights into the mechanism of signal transduction. 
2.3 Experimental procedures 
Protein Expression & Purification 
LEP-R[D1-D7], LEP-R[D1-D5], LEP-R[D1-D7]-GCN4, and LEP-R[D3-D5] constructs 
were subcloned into the baculovirus FastBac pH7pFB LIC expression vector including a 
secretion signal sequence. Recombinant viruses were used to infect Sf9 cells and the 
protein constructs were purified from the supernatant using Ni-NTA Agarose affinity 
beads (Qiagen, USA). The samples were further purified by size exclusion 























complex formation, purified LEP-R proteins constructs were incubated with excess 
recombinant mouse leptin (R&D Systems, Inc., USA). The liganded complexes were 
subsequently purified by SEC to remove excess leptin, and the purity of the samples was 
determined by SDS-PAGE stained with Coomassie Blue dye (Figure 1). LEP-R[D1-D7] 
L503S;L504S and LEP-R[D1-D7] L370A mutants were generated with Quick Change 
Mutagenesis® (Stratagene), subcloned into FastBac pH7pFB LIC expression vector, and 
purified as described above (Figure 2.18) 
Effect of different reducing reagents on leptin 
Leptin may form both intra and inter disulfide bonds making its existence as a dimer and 
monomer a dynamic process. In order to assess the effect of different reducing agents on 
leptin dimer formation, the commercially acquired leptin was incubated with different 
concentrations of dithiothreitol (DTT), tris (2-carboxyethyl)phosphine (TCEP) and β-
mercaptoethanol (βME), samples were boiled, ran on SDS-PAGE gels and silver stained. 
Interestingly, DTT and TCEP were effective to reduce the dimer to monomer at both low 
and high concentrations. On the other hand,  β-ME was only effective at concentration of 
over 100mM.  
Isothermal Titration Calorimetry 
Titrations were performed on a NanoITCTM – Low Volume calorimeter (TA Instruments) 
at 25 °C. Data were processed with the NanoAnalyze software. Briefly, both LEP-R[D1-
D7] (11.4 M) and LEP-R[D1-D5] (13 M) were titrated with leptin (75 M) (Figure 2.11 a, 
c). The titrations showed ~1:1 complex formation for both constructs and indicated high 
affinity leptin binding (KD=17.0 nM and KD=15.4 nM, respectively). The experiment was 
performed in 20mM HEPES, pH 8.0, 50mM NaCl at 25°C, 2µl/injection, 300 sec/inj., 250 
rpm stirring, high feedback, 0.190 ml cell volume. 
Analytical Ultracentrifugation (AUC) 
Sedimentation velocity experiments were carried out using a ProteomeLab XL-I 
(Beckman Coulter). Sample triplets were loaded into sector-shaped double channel 
centerpieces and sedimentation was carried out at 20,000 rpm, 22°C using an AN50TI 
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rotor. Intensity scans were collected continuously at a wavelength of 235 nm at a radial 
resolution of 30 µm. Data analysis was with the enhanced van Holde-Weischet analysis 
module and 2-dimensional sedimentation spectrum analysis (2-DSA) using the finite 
element modeling module provided with the Ultrascan3 software 
(http:/www.ultrascan.uthscsa.edu). Sedimentation profiles were analyzed at a grid 
resolution of 60 using 20 grid repetitions fitting time- and radial invariant noise. 
Confidence levels were derived from 2-DSA data refinement using genetic algorithm 
followed by 30 Monte Carlo simulations. Calculations were performed on the UltraScan 
LIMS cluster at the Bioinformatics Core Facility at the University of Texas Health 
Science Center at San Antonio and the Lonestar cluster at the Texas Advanced 
Computing Center supported by NSF Teragrid Grant #MCB070038 (to Borries Demeler). 
Electron Microscopy  
Protein samples were prepared for electron microscopy using the conventional negative 
staining protocol (Ohi et al., 2004), and imaged at room temperature with a Tecnai T12 
electron microscope operated at 120 kV using low-dose procedures. Images were 
recorded at a magnification of 71,139x and a defocus value of ~1.6 µm on a Gatan 
US4000 CCD camera. All images were binned (2 x 2 pixels) to obtain a pixel size of 4.16 
Å on the specimen level. Particle projections were manually excised using Boxer [part of 
the EMAN 1.9 software suite] (Ludtke et al., 1999) apart from tilt-pair images, where 
particles were selected using WEB (Frank et al., 1996).  
Image Processing 
Reference-free alignment and classification for the projection analysis of LEP-R and 
leptin/LEP-R complexes were carried out using the SPIDER image processing suite 
(Frank et al., 1996). For LEP-R[D1-D7], 23,933 particle projections were classified into 
100 classes (Figure 2.14a). For LEP-R[D1-D5], 8,352 particle projections were classified 
into 80 classes (Figure 2.14b). For the leptin/LEP-R[D1-D5] complex, 5,215 particle 
images were classified into 100 classes (Figure 2.16c,d). For the LEP-R[D1-D7] 
L503S;L504S mutant, 6,189 particle images were classified into 50 classes (Figure 2.18 
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c). For the leptin/LEP-R[D1-D7] L370A mutant complex, 4,964 particle images were 
classified into 50 classes (Figure 2.18 f). 
For the leptin/LEP-R[D1-D7] complex, 20,065 tilt-pair particle projections  were 
interactively selected from 0º and 60º tilted images.  To analyze the challenging 
projection variability of the entire extracellular liganded receptor chains and calculate 3D 
reconstructions we employed a three-step process: In the first step, the untilted particle 
images were subjected to 10 cycles of reference-free alignment and classification into 
300 classes (Figure 2.16a). In the second step, particles belonging to class averages with 
poor features and misaligned projections were removed from the dataset, and the 
remaining 13,616 projections were subjected to another round of iterative classification 
and alignment into 150 classes (Figure 2.16b). In the third step, we created separate 
particle sub-groups including projections displaying a specific type of conformation or 
composition. Thus, we created subgroups for the binary leptin/LEP-R[D1-D7] complex 
(liganded single chains), and for the side and top views of the leptin/LEP-R[D1-D7] 
quaternary complexes (Figure 2.16 b, d and 2-17a). This approach allowed us to probe 
the fine variability within each type of projection, and also select well-defined class 
averages for 3D reconstructions. The random conical tilt technique (Radermacher et al., 
1987) was used to calculate a first back projection map from individual classes using the 
images of the tilted specimen.  After angular refinement, the corresponding particles from 
the images of the untilted specimens were added, and the images were subjected to 
another cycle of refinement.  Using the resulting maps as reference models, we used 
FREALIGN (Grigorieff, 2007) for further refinement of the orientation parameters. The 
3D maps of the binary leptin/LEP-R[D1-D7], and of the side and top views of the 
leptin/LEP-R[D1-D7] quaternary complexes were based on 2,374, 1,194, and 772 0º and 
60º projections, with indicated resolutions of 40Å, 40Å and 45Å, respectively. 
 
Molecular Modeling and Docking 
The model of LEP-R[D1-D7] was built from the first five domains of the crystal structure 
of LIF-R (Huyton et al., 2007; Skiniotis et al., 2008) and the last two membrane proximal 
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FnIII domains from the crystal structure of gp130 (Xu et al., 2010) (Figure 2-15c). The 
binary and quaternary leptin/LEP-R[D1-D7] models were built by aligning the 
homologous domains from crystal structures of gp130/IL-6 (Boulanger et al., 2003b), 
GCSF/GCSF-R (Tamada et al., 2006), LIF-R (Huyton et al., 2007; Skiniotis et al., 2008), 
and leptin (Zhang et al., 1997). Due to the limited resolution of the 3D maps, all docking 
operations in the EM densities were performed manually with visual inspection of the 
best fit. The binary leptin/LEP-R[D1-D7] model and the gp130/IL-6 crystal structure 
were fit as rigid bodies into the 3D maps of the binary complex and the top view of the 
quaternary complex, respectively (Figures 2-15 f, 2-19e). For the 3D map from side 
views of the quaternary complex, two liganded leptin/LEP-R[D1-D7] models were 
flexibly fit into the EM densities (Figure 2-19b).  
2.4 Results  
Purification trials for LEP-R 
The CaCl2/NiCl2 precipitation method 
Expressing and purifying secreted proteins from insect cells can be very challenging due 
to the large volume of media to be handled. There are components in the insect cell 
media that will strip a Ni resin and that is why the media cannot be applied directly to the 
Ni-NTA. Therefore, one-way to adapt the media for passage though the Nickel is to 
precipitate out the interfering components by CaCl2/NiCl2 precipitation. All steps are 
carried out at a room temperature. Cells are spun and the media is filtered through a 
0.2um filter. To each liter of cell the following mixture is added: 
1 ml of 1M Nickel Chloride 
1ml of 5M Calcium Chloride 
50ml of 1M Tris pH 8 
Once the precipitation mixture is added, a heavy white precipitate will form immediately. 
The cells are spun again at least 6000rpm for 15 minutes. After filtration through a 0.2um 
filter the media is poured into a beaker with a stir bar and 2ml of Nickel slurry is added to 
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each liter of cells. Incubation is carried out for at least 3 hours at room temperature. The 
resin is then collected into a polyprep column and washed with 1x HBS and then eluted 
with 250mM imidazole. It is extremely important to keep the media at room temperature 
otherwise the Ni resin will be lost in the heavy white precipitate again which will form if 
the temperature is decreased. 
 
Figure 2-4 Analysis of protein purified with the precipitation method 
 a. SEC of FL LEP-R b., SDS silver stained gel of SEC fractions and bottom anti-His 
Western blot of SEC fractions. 
 
In this method the results are difficult to reproduce and usually the proteins are very hard 
to separate from other contaminants even after affinity and size exclusion steps (Figure 
2-4). In addition, adding any components to the media prior or during the Ni incubation 
step also leads to precipitation. Therefore, this method is not the ideal way to purify 
secreted proteins. 
Buffer exchange method 
Another way to strip the media from its interfering components before the Ni application 
is to exchange buffer for HBS overnight. This method also requires handling very large 
volumes and is unpractical to carry out for expression volumes over 1.5L. The reason is 
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that the need to have at least 10X the amount of buffer in the beaker with the media to be 
exchanged. Therefore, for high protein concentration this method is unsuitable. However, 
for small volume protein purifications, buffer exchange overnight yields media that could 
be passed through the Ni-NTA resin without stripping it. 
 
Figure 2-5 SDS-PAGE silver stain (top) and anti-His Western (bottom). 
Different purification fractions from full length extracellular LEP-R purified by buffer 
exchange method. 
Moreover, proteins purified with this method may be subject to degradation as illustrated 
from the Western blot in Figure 2-5 above. Also, the contaminants are difficult to 
separate from the target protein even after a gel filtration step. 
DEAE ion exchange purification method 
The diethylaminoethyl (DEAE) cellulose is an ion exchange resin that was tested against 
the insect media as a buffer exchange step. The ion exchange relies on the reversible 























exchange of ions in solution with ions that are bound electrostatically to the resin. 
Whether or not the protein interacts with the resin and binds or flows through depends on 
its net charge, which depends on the isoelectric point of the protein and the buffer pH.. 
Thus, making the protein more negatively charged could be accomplished by raising the 
pH or more positively charged by lowering the pH and this will ultimately dictate its 
binding to the ion exchange resin. DEAE cellulose is a positively charged resin that is 
capable of locking negatively charged proteins. Therefore, when LEP-R in insect cell 
media is passed through the DEAE it flows through while all media interfering 
components are retained. This method is not very effective because of the unspecific 
binding of LEP-R to the DEAE. 
 
 
Figure 2-6 DEAE cellulose purification of full length extracellular LEP-R and LEP-
R-GCN4. 
SDS-PAGE analysis of different purification fractions for LEP-R constructs. 
As the figure above illustrates most of the protein flows through the DEAE but more 
importantly about 50% remains   on the resin (Figure 2-6). Although, most of it could be 
eluted with competing sodium chloride, the amount lost in the process that subsequently 



















































































DEAE is very laborious and time consuming. Therefore, this method is not practical for 
efficient and clean purification of secreted proteins. 
The Millipore concentrator method 
This method is the most successful one in dealing with large volumes of media. Here, 
after the cells have been collected, spun and filtered, the media is applied through the 
concentrator and the media volume is brought down to 10X. For example, if the starting 
expression volume is 5L, the concentrator allows for concentrating down to 500ml. Then, 
the final volume is buffer-exchanged overnight and the purification protocol is carried as 
usual in the following day. In addition to allowing a large-scale purification of secreted 
proteins, this method also provides a faster and less error prone methodology in handling 
sensitive secreted proteins. This method provides a fast and reliably reproducible 
approach for purification of secreted proteins and is therefore the preferred one for 
purification of the LEP-R constructs in this thesis. 
Effect of vector type, infection time and insect cell line on protein expression 
The Baculovirus protein expression has many advantages for producing recombinant 
mammalian proteins because it permits post-translational modifications such as 
phosphorylation, disulfide bond formation, proper protein folding, glycosylation and even 
signal peptide cleavage. Baculoviruses are well known in their ability to infect insects. 
They contain a double stranded, supercoiled DNA inside of a rod-shape capsid (Summers 
and Anderson, 1972). One of the most prominent isolate used in foreign gene expression 
is the Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) and the 
Orgyia pseudotsugata muticapsid nuclear polyhedrosisvirus (OpMNPV), used for 
expression of the LEP-R constructs (Brown et al., 2011). The disadvantages of this 
system are that the process is quite lengthy (about 2 months from cloning to protein 
expression), contains multiple steps, many variables, few control check points and can 
get expensive for large scale protein production. Nevertheless, the Baculovirus 
expression usually works where E. coli fails to produce the target protein with all the 
needed post-translational modifications. 
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Depending on the target protein either Spodoptera frugipedra (Sf9) or Trichoplusia ni 
(Hi5) insect cells can lead to better expression. In addition, the allowed time post 
infection as well as the type of vector used can also influence expression. 
 
Figure 2-7 Effect of cell type, vector and time of post-infection on protein 
expression.  
a., Expresion in Sf9 cells for different constructs and times. Arrows point to 
overexpressed protein. b., Expression in Hi5 cells for different constructs, vectors and 
time. Arrows point to overexpressed proteins. (Courtesy of Clay Brown) 
The expression of LEP-R constructs gave best yield in Sf9 cell, at 48 hours post-infection 
and in vectors containing the Ac64 and Op64 signal sequences (Figure 2-7). 
Effect of different reducing reagents on leptin 
Leptin may form both intra and inter disulfide bonds making its existence as a dimer and 
monomer a dynamic process. In order to assess the effect of different reducing agents on 
leptin dimer formation, commercial leptin was incubated with different concentrations of 
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dithiothreitol (DTT), tris (2-carboxyethyl)phosphine (TCEP) and β-mercaptoethanol 
(βME), samples were boiled, ran on SDS-PAGE gels and silver stained. Interestingly, 
DTT and TCEP were effective to reduce the dimer to monomer at both low and high 
concentrations which β-ME was only effective at concentration of over 100mM (Figure 
2-8).  
 
Figure 2-8 Effect of different reducing agents on leptin.  
Commercially available leptin was mixed with different reducing agents and samples 
were analyzed with SDS-PAGE. The gels were silver stained and clearly reveal the leptin 
dimeric and monomeric species. 
 
Assembly of the Extracellular Leptin/LEP-R complex 
For the present study we used a baculovirus system to express the entire extracellular 
region (domains D1-D7) of murine LEP-R and a truncated construct of the same protein 
lacking the two membrane-proximal FnIII domains (D1-D5). Both protein constructs 
were engineered with an N-terminal His-tag facilitating nickel affinity purification, and 
































































































Figure 2-9 Size exclusion chromatography of LEP-R[D1-D7] and LEP-R[D1-D5]. 
After Ni-affinity purification of LepR constructs, the elution fractions were concentrated 
and applied to size exclusion chromatography separation. Only fractions under the 
highest peak were used for subsequent EM analysis. 
To evaluate the leptin/LEP-R complex formation and the binding stoichiometry, we 
employed analytical ultracentrifugation (AUC) and isothermal titration calorimetry (ITC) 
to measure the thermodynamics of the interaction. Both methods suggested 1:1 
stoichiometry of the complex although the ITC provided smaller error.  
The sedimentation velocities of both LEP-R[D1-D7] and LEP-R[D1-D5] constructs were 




Figure 2-10 Analytical Ultracentrifugation of LEP-R[D1-D7] and LEP-R[D1-D5] in 
the presence of excess leptin.  
Densitometry graph representing relative concentration of different species related to 
their sedimentation coefficient and relative mass. Data is generated by Titus Franzmann. 
 
The results from the AUC show multiple populations in the mixture after the 
sedimentation was carried. In fact, the concentration of dimerized leptin was higher than 
the monomeric species. This in turn increased the bias of whether complex formation was 
due to ligand dimerization or a dimerization of receptor and ligand. The major species in 
the mixture consisted of two receptors and two ligands. However, there was also a small 
population of monomeric receptor chains bound to leptin and some higher order species. 
For both the D1-D7 and D1-D5 constructs, the ITC measurements suggested that leptin 
engages LEP-R with high affinity interaction with KD value of ~17 nM, providing a first 
indication for stoichiometric complex formation in a 1:1 ratio (Figure 2-11 a, c).    We 













murine leptin and used size exclusion chromatography to isolate liganded receptor 
complexes for subsequent analysis (Figure 2-11 b, d).  
 
Figure 2-11 Thermodynamic Analysis and Purification of the leptin/LEP-R[D1-D7] 












































a, Isothermal titration calorimetry for the assembly of leptin and LEP-R[D1-D7] 
complex. b, Size exclusion chromatography profile and SDS-PAGE analysis of purified 
liganded LEP-R[D1-D7]. c, Isothermal titration calorimetry for the assembly of leptin 
and LEP-R[D1-D5] complex. d, Size exclusion chromatography profile and SDS-PAGE 
analysis of purified liganded LEP-R[D1-D5]. 
Rigid Membrane-Proximal Domains Connected to a Flexible CHR2 
As a first step in our structural analysis we examined unliganded LEP-R[D1-D7] and 
LEP-R[D1-D5] preparations by negative stain EM. Both samples revealed monodisperse 










Figure 2-12 Raw EM images of LEP-R[D1-D7] and leptin/LEP-R[D1-D7] complex. 
a, raw micrograph of negatively stained LEP-R[D1-D7], individual particles to the right. 
b, raw micrograph of leptin/LEP-R[D1-D7] complex, individual particles to the right 
(Mancour et al., 2012). 
 
 
Figure 2-13 Raw EM images of LEP-R[D1-D5] and leptin LEP-R[D1-D5] complex 
a, raw micrograph of negatively stained LEP-R[D1-D5], individual particles. b, raw 
micrograph of leptin/LEP-R[D1-D5] complex, individual particles (Mancour et al., 
2012). 
The samples were analyzed and classified according to the reference-free protocol. Class 









like structure of approximately 21 nm in length, which displays a characteristic ‘V’ shape 
closer to one end (Figure 2-14a, Figure 2-15 a). 
 
Figure 2-14 Final 2D classifications of LEP-R[D1-D7] and LEP-R[D1-D5] 
a., 23,933 particle projections classified into 100 classes. b., 8,352 particle projections 
classified into 80 classes (Mancour et al., 2012). 
Comparison of EM averages from the D1-D7 construct and the shorter D1-D5 construct 
(~16.5 nm) reveals the orientation of the LEP-R termini with the ‘V’ shape being closer 
to the N-terminus (Figure 2-15a, b). A higher density lobe at the C-terminus of the D1-
D7 construct suggests that the two membrane-proximal FnIII domains likely assume a 
sharp bend, similar to what has been observed in the crystal structure of the gp130 
ectodomain (Xu et al., 2010). Beyond the membrane-proximal domains, the observed 
structure is highly reminiscent to the extended “flying V” architecture observed in the 
crystal structures of murine and human LIF-R (Huyton et al., 2007; Skiniotis et al., 2008) 






canonical bent elbow shape commonly seen in other cytokine receptors, while the IgD 
(D3) is centrally positioned at the base of the ‘V’. Given the highly similar extracellular 
domain architecture of LIF-R[D1-D5] and gp130[D1-D6], and also the similarities with 
the recently solved structure of LEP-R CHR2 region (Carpenter et al., 2012), we aligned 
and merged their available crystal structures to produce a homology model for the entire 
extracellular region of LEP-R (Figure 2-15c). This model is in striking agreement with 
the projection averages of LEP-R, indicating the common domain organization of the tall 




Figure 2-15 Conformational dynamics of LEP-R in unliganded and liganded states 
a., representative two-dimensional class averages of unliganded LEP-R[D1-D7] reveal 
significant flexibility in the hinge between D4 and the rigid D5-D7 module (white arrow 
heads). b., two dimensional class averages of unliganded LEP-R[D1-D5] confirm the 
domain assignments and the variable deposition of D5 (white arrowheads) in regards to 
D4. c., Comparison of the crystal strucutres from LEP-R, gp130 and LIF-R extracellular 
domain and homology model for LEP-R[D1-D7 d., Representative two-dimensional class 
average of the binary leptin/LEP-R[D1-D7] complex. The cytokine binds to CHR2 
resulting in the stabilization of the rigid D5-D7 module in a single conformation. e., 
Representative two-dimensional class average the binary leptin/LEP-R[D1-D5] complex. 
The orange and white arrowheads point to the leptin density and the LEP-R C terminus, 
respectively. f., Three-dimensional reconstruction of the binary leptin/LEP-R[D1-D7] 
complex with docked leptin/LEP-R homology model. g., The double mutation 
L503S/L504S on D4 of Lep-R abolishes leptin binding via epitope II. EM class averages 
of this mutant after incubation with  leptin reveal only monomeric receptor chains with no 
ligand bound at CHR2 (compare to a and d). All scale bars correspond to 5 nm (Mancour 
et al., 2012). 
Interestingly, D5 of CHR2 and the two membrane-proximal FnIII domains (D6-D7) are 
well defined and assume the same angle, suggesting that they behave as a rigid body 
(Figure 2-15a). However, the orientation of the D5-D7 module in respect to the central 
‘V’ is highly variable and assumes a continuum of angles with a range of ~40° in the 
plane of the carbon support of the EM grid. This observation suggests that the linker 
connecting the two domains composing CHR2 (D4-D5) is highly flexible and allows for 
variability in the relative configuration of the connected domains. Indeed, examination of 
class averages of the truncated construct lacking the FnIII ‘legs’ (D6-D7) clearly reveals 
that D5 assumes variable positions around D4 with the same angular range observed in 
the full-length extracellular construct (Figure 2-15 a, b). 
Leptin Engages CHR2 to Stabilize the Membrane-Proximal Domains 
In a next step we examined leptin/LEP-R complexes by negative stain EM. Raw images 
of this preparation revealed monodisperse particles with variable shapes (Figure 2-12 b, 
Figure 2-13 b), which represent different orientations or configurations adopted by 
individual complexes when adsorbed on the carbon support of the EM grid. This 
characteristic projection variability has been previously observed in our earlier studies 
involving gp130 (Skiniotis et al., 2005), gp130/LIF-R (Skiniotis et al., 2008), and 
vascular endothelial growth factor receptor (VEGF-R) (Ruch et al., 2007) liganded 
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complexes. Similarly to those studies, we applied a three-step strategy of reference-free 
alignment and classification, enabling us to analyze the projection variability of the 
receptor chains and calculate 3D reconstructions (for a detailed description see materials 

















Figure 2-16 Steps in analyzing the challenging projection variability. 
a, 20,065 particle projections of the leptin/LEP-R[D1-D7] complex classified into 300 





classes after removing the misaligned projections as well the ones with poor features. c, 
17,106 particle projection of the leptin/LEP-R[D1-D5] complex into 200 classes. d, 5,215 
particle projections of the leptin/LEP-R[D1-D5] complex into 100 classes (Mancour et 
al., 2012). 
A fraction of the particles from the liganded LEP-R[D1-D7] and LEP-R[D1-D5] 
complexes reveal a single preferred orientation of monomeric chains with an additional 
distinct globular density towards the middle of the receptor, at the junction between 
domains D4 and D5 (Figure 2-15 d, e; approximately 15% and 25% of particles, 
respectively). The extra density can only be attributed to a leptin molecule bound to 
CHR2. This type of interaction has been previously observed in the signaling complexes 
of IL-6 with gp130 (Boulanger et al., 2003b; Skiniotis et al., 2005) and GCSF with 
GCSF-R (Tamada et al., 2006), where the cytokines use epitope II to interact with the 
elbow of the CHR module, and is in agreement with earlier mutagenesis studies 
(Iserentant et al., 2005). To support this interpretation, we calculated a 3D reconstruction 
of the liganded monomeric LEP-R chain and compared it to our homology model 







Figure 2-17 2D classification and 3D reconstructions of leptin/LEP-R[D1-D7] 
projection sub-groups. 
a, Sub-group 0° projections from ‘STEP 3’ (see methods) were individually classified to 
fine-tune the alignment and facilitate 3D reconstruction by the random conical tilt 
approach. b, 3D reconstructions of binary and quaternary leptin/LEP-R[D1-D7] 
complexes (Mancour et al., 2012). 
Docking of the model in the 3D map shows a very good fit, reinforcing our analysis on 
the leptin/LEP-R interaction. Furthermore, we produced and analyzed a LEP-R[D1-D7] 
construct bearing the mutations L503S;L504S at the CHR2, as originally described by 
Tavernier and colleagues (Iserentant et al., 2005). As expected, incubation of this mutant 
with leptin did not result in a binary complex formation, and EM analysis showed that 
there was no additional distinct globular density attached to the region that we attributed 
to CHR2 (Figure 2-15 g and Figure 2-18). Interestingly, none of the averages from 
monomeric receptor chains display leptin density at the level of the IgD (D3), located at 
the base of the flying ‘V’ architecture (Figure 2-15 d, e). These observations suggest that 
the CHR2 of LEP-R represents the primary site for leptin binding via a high-affinity 
interaction, as also supported by our binding thermodynamics data (Figure 2-10 and 
Figure 2-11 a, c). Importantly, the liganded monomeric LEP-R chains from both 
extracellular constructs do not display any variability in the relative disposition of the D4 
and D5 domains of CHR2. Class averages from this population reveal a distinct single 
conformation of the D5-(D6-D7) module with a fixed angle in relation to the membrane-
distal domains (Figure 2-17). Thus, leptin binding on CHR2 constrains D5 and the rigidly 
attached membrane-proximal FnIII domains (D6-D7) in a fixed orientation towards the 




Figure 2-18 Purification and 2D classification of LEP-R[D1-D7] L503S/L504S and 
L370A mutants after incubation with leptin. 
 a, SEC of LEP-R[D1-D7]L503S/L504S after incubation with leptin. b, Raw image of 
negative stained sample from the fraction shown in (a). c, 6,189 particle projections 
classified into 50 classes. d, SEC of LEP-R[D1-D7]L370A after incubation with leptin. e, 
Raw image of negative stained sample from the fraction shown in (d). f, 4,964 particle 






















Liganded LEP-R Assembles into 2:2 Quaternary Complex 
The majority of leptin/LEP-R complexes in our classification display variable views of 
dimeric LEP-R chains. A prominent set of class averages reveals a characteristic side 
view of the complex, where the two LEP-R chains appear to be crossing at the level of 
the CHR2 module, while both the CHR1 and the membrane-proximal modules remain 
unengaged (Figure 2-19 a). This interpretation was confirmed by 3D reconstructions and 
molecular docking, showing that the LEP-R chains cross over to opposite sides at the 
level of CHR2 and IgD (Figure 2-19 b). In most class averages the two LEP-R chains 
appear asymmetric, presumably due to the projection angle and distortion of the receptor 
chains on the carbon support of the EM grid, as was also the case with our study on the 
gp130/IL6/IL6-R complex (Skiniotis et al., 2005). In support of this notion, averages of 
relatively few particles in our population show a perfectly symmetric dimeric complex 
formation (Figure 2-16 and Figure 2-17). Nevertheless, in all projection averages where 
the two LEP-R chains are clearly distinguished the membrane-proximal domains appear 
to be constrained and point towards each other (Figure 2-19 a). This conformation 
reflects the same fixed geometry observed in the liganded monomeric LEP-R chains 
(Figure 2-19 d-f). In the context of the signaling LEP-R dimer, leptin induced 
stabilization of CHR2 appears to result in fixing the two membrane-proximal domains 




Figure 2-19 Architecture of the Quaternary Leptin/LEP-R Signaling Complex. 
a, Two-dimensional class averages of side-view projections reveal the crossover 
configuration of two LEP-R extracellular chains. The two chains connect at the CHR2 
level, while the membrane proximal domains (white arrowheads) point toward each other 
and arrive in close proximity at their C-terminal tips. b, Three-dimensional reconstruction 
of the leptin/LEP-R side-view projections shown in (a). Flexible docking of two liganded 
LEP-R chains into the three-dimensional density map shows the complex configuration 
(right). c, Representative two-dimensional class average of a top view of the quaternary 
leptin/LEP-R [D1-D7] complex. In this type of projections the N-terminal CHR1 and C-
terminal FnIII domains are collapsed on the carbon support (black arrowheads). The 
boxed area shows the rectangular formation that is reminiscent of the anti-parallel 
gp130/IL-6 or GCSF/GCSF-R interaction. d, Representative two-dimensional class 
average of a top view of the quaternary leptin/LEP-R[D1- D5] complex, as in (c). The 
dashed white arrowheads point to missing densities from the omitted C-terminal domains 
of the truncated construct, as compared to (c). e, Three-dimensional reconstruction from 
topview leptin/LEP-R[D1-D7] projections shown in (c), and docked gp130/IL-6 crystal 
structure into the central rectangular density of the three-dimensional map (right). f, 
Mutation L370A on the IgD (D3) of LEP-R abolishes leptin binding via epitope III. EM 
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class averages of this mutant after incubation with leptin reveal only monomeric receptor 
chains with ligand bound at CHR2 (orange arrows). All scale bars correspond to 5 nm 
(Mancour et al., 2012). 
The 3D reconstruction from the side view particle projections has limited resolution in 
the plane perpendicular to the electron beam, and thus does not provide adequate detail 
for elucidating the arrangement between leptin and LEP-R in the context of the dimeric 
receptor complex. However, an abundant series of class averages reveals a top view of 
the complex (Figure 2-19c), reminiscent to the top views we characterized in our earlier 
study of the gp130/IL6/IL6-R complex (Skiniotis et al., 2005). Here, we also recognize a 
central rectangular formation with a distinct stain accumulation region in the center, 
suggesting a hole or cavity in this position. Emanating from the rectangle in the LEP-R 
top view are the projections from membrane-proximal FnIII and N-terminal CHR1 
domains that collapse in a distinct fashion on the carbon support (pointed by arrows in 
Figure 2-19c). The rectangular cap architecture represents the top view of the tetrameric 
arrangement between leptin and LEP-R that follows the identical topological blueprint of 
the gp130/IL-6 (Skiniotis et al., 2005) or GCSF/GCSF-R interaction (Tamada et al., 
2006). In this arrangement, while epitope II of leptin interacts with the CHR2 (D4-D5) of 
LEP-R, epitope III engages the IgD (D3) of the second, opposing receptor. This set of 
interactions, which was also observed in class averages of complexes formed by the 
truncated LEP-R chains (Figure 2-19d), results in the formation of a closed tetrameric cap 
with antiparallel subunits of leptin and LEP-R. This organization is further supported by 
the good fit of the gp130/IL-6 structure (Boulanger et al., 2003b) in the 3D EM 
reconstruction of the collapsed top view of the leptin/LEP-R complex (Figure 2-19e), and 
also by the good match between our 2D projections and reprojections of a quaternary 3D 




Figure 2-20 Projection comparison. 
Comparison between reprojections of the 3D homology model of the quaternary 
leptin/LEP-R[D1-D7] complex (left) and experimental 2D class averages (right) 
(Mancour et al., 2012). 
To fully confirm this interpretation, we produced and analyzed a LEP-R[D1-D7] 
construct bearing the IgD mutation L370A, which has been previously shown to abolish 
leptin signaling (Peelman et al., 2006b). EM analysis of this IgD mutant LEP-R reveals 
that while it forms the binary complex with leptin through CHR2, it is unable to form the 
signaling quaternary complex that is based on the interaction of the IgD with epitope III 
of leptin (Figures 2-19f and 2-18d-f). Thus, the quaternary signaling leptin/LEP-R 
2D class averagesReprojections from
3D model




complex forms in a 2:2 stoichiometry by following the same organizing principles as 
gp130/IL6 and GCSF/GCSF-R complexes (Figure 2-21).  
 
Figure 2-21 Signaling Architecture of Tall Cytokine Receptors. 
Receptor organization and ligand epitope usage in the signaling complexes of gp130/IL-
6/IL-6Ra (a, left), gp130/LIF-R/CNTF/ CNTF-Ra (a; right), and leptin/LEP-R (b, left). 
Leptin employs only epitopes II and III to engage the CHR2 and IgD of LEP-R, 
respectively. Leptin-induced stabilization of each CHR2 in the quaternary complex 
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results in the constrained and close disposition of the membrane-proximal domains, 
which likely favors intracellular Jak2 transphosphorylation (b, right) (Mancour et al., 
2012). 
2.5 Discussion  
Reduced or deficient leptin signaling causes hyperphagia and morbid obesity in both 
animals and humans (Zhang et al., 1994), while administration of leptin has been shown 
to reduce food intake and body weight (Pelleymounter et al., 1995). Paradoxically, most 
obese patients display elevated levels of leptin, which underlines the so-called “leptin 
resistance”, a term used to describe the failure of high levels of leptin to prevent obesity 
(Considine et al., 1996; Frederich et al., 1995; Myers et al., 2008). One of the main 
causes of leptin resistance is the impairment of leptin receptor function and signaling that 
also results in obesity and associated metabolic diseases (Munzberg et al., 2005; Oswal 
and Yeo, 2010; Prosnak, 1976; White et al., 1997). For example, the originally described 
db/db obese mice lack the leptin receptor, and they resemble the leptin-deficient ob/ob 
mice (Clement et al., 1998; Friedman and Halaas, 1998; Hummel et al., 1966; Ingalls et 
al., 1950; Montague et al., 1997). Therefore, the elucidation of the molecular mechanism 
of leptin receptor activation is a key issue for the design of appropriate therapeutic 
strategies. Considering the diverse signaling events and significant physiological 
responses exerted by leptin, both stimulation and inhibition of the leptin receptor have 
pharmacological applications in disease treatment (Peelman et al., 2006a). 
For the present study we employed single-particle EM to characterize the architecture of 
the entire extracellular LEP-R alone and in complex with leptin. The unliganded 
extracellular receptor appears highly similar to the crystallographic structures of 
extracellular regions from gp130 (Xu et al., 2010), LIF-R (Huyton et al., 2007; Skiniotis 
et al., 2008), and GCSF-R (Tamada et al., 2006) (Figure 2-15). This result is perhaps not 
unexpected, considering the high sequence similarity and common domain organization 
of tall cytokine receptors. Nevertheless, this finding reinforces the notion that the overall 
architecture of tall cytokine receptors is relatively constrained, although the extracellular 
chains are composed of an array of linker-connected FnIII and Ig-like domains. A 
puzzling issue however is that crystal structures of gp130 and LIF-R show the same 
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receptor conformation in the presence and absence of the ligand, with a CHR2 
configuration that is similar to the one observed in the recently determined crystal 
structure of LEP-R CHR2 in complex with a Fab fragment (Carpenter et al., 2012). Here 
we show that LEP-R displays significant flexibility in the hinge region connecting the D4 
and D5 domains composing CHR2, which presumably allows the membrane-proximal 
domains to assume variable configurations in the absence of ligand. In contrast, leptin 
binding on CHR2 of LEP-R rigidifies the position of D5, thereby stabilizing the 
membrane-proximal FnIII domains (D6-D7) in a single conformation (Figure 2-15 d-f). 
The obtained LEP-R homology model, based on gp130 and LIF-R unliganded crystal 
structures, fits well in the 3D reconstruction of monomeric LEP-R in complex with leptin 
(Figure 2-15 c, f). This observation suggests that crystallization conditions may have 
induced the unliganded receptors to assume the same conformation as in the presence of 
ligand.  
The 2D projection analysis reveals that all monomeric LEP-R chains in the presence of 
ligand display stable leptin binding on CHR2. This finding indicates that CHR2 is the 
primary site for leptin binding with a high-affinity interaction, as supported by our ITC 
experiments and earlier biochemical studies (Fong et al., 1998; Iserentant et al., 2005). 
Based on the homologous interactions observed for gp130 (Boulanger et al., 2003b) and 
GCSF-R (Tamada et al., 2006), the LEP-R CHR2 interaction must be maintained through 
epitope II of leptin, as also supported by mutagenesis studies (Iserentant et al., 2005) 
(Figure 2-21a).  
Similar to the other hematopoietic cytokines, leptin possesses two additional conserved 
epitopes with the potential to be engaged in receptor binding. 3D reconstructions and 
modeling suggest that conserved epitope III of leptin is used for engaging the IgD (D3) of 
the second receptor chain that is juxtaposed in an antiparallel fashion. In the case of 
gp130 homodimers and heterodimers (e.g., gp130/LIF-R), epitope I is used to engage the 
CHR of a non-signaling α-receptor (e.g., IL6-Rα or CNTF-Rα) that is required for 
signaling complex formation (Boulanger et al., 2003b; Skiniotis et al., 2008) (Figure 2-
21a). However, the leptin/LEP-R signaling complex does not include a non-signaling α-
receptor. This omission has led to the proposal that four LEP-R chains participate in the 
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signaling complex through the additional engagement of epitope I. This is clearly not the 
case, as we show here that the signaling complex between leptin and LEP-R forms at a 
2:2 stoichiometry, by engaging only leptin epitopes II and III (Figure 2-21 a,b). 
Curiously, the N-terminal CHR1 of LEP-R does not appear to participate in any 
interactions, as has also been the case with the CHR1 of LIF-R in the gp130/LIF-
R/CNTF/CNTF-Rα complex (Skiniotis et al., 2008). It will thus be interesting to examine 
whether these regions have a different type of functionality that is independent of 
signaling. 
It is also worth noting that our results explain the absence of observed leptin density 
interacting with the IgD (D3) in monomeric LEP-R chains. Similarly to the gp130/IL6 
system (Boulanger et al., 2003b), the epitope III interaction has undetectably low affinity 
for LEP-R IgD alone, and is only stabilized by the avidity afforded by the “two-point 
attachment” between preformed and antiparallel leptin/LEP-R dimeric complexes. In this 
context, the mode of complex formation is likely cooperative, with leptin binding first to 
the CHR2 of one LEP-R with a 1:1 stoichiometry, followed by two liganded LEP-Rs 
engaging at the membrane distal regions (Figure 2-21b). 
Earlier work on gp130 and gp130/LIF-R signaling complexes has shown that the 
membrane-proximal FnIII domains of two juxtaposed receptors bend towards each other 
to reach the same position at the membrane level (Skiniotis et al., 2005; Skiniotis et al., 
2008). Within this family of receptors, LEP-R is the only member possessing two, rather 
than three, FnIII domains connecting the distal cytokine binding regions to the cell 
membrane. Perhaps this “handicap” is utilized to differentiate LEP-R in the types of 
intracellular signaling exerted by the liganded receptor. Nevertheless, we show here that 
the FnIII ‘legs’ in the leptin/LEP-R quaternary signaling complex also point towards each 
other and come in close proximity at their C-terminal tips. For the tall class of cytokine 
receptor liganded complexes the present study shows that this configuration of the FnIII 
‘legs’ is induced and stabilized by the binding of the cytokine on the flexible CHR. In the 
absence of ligand, the membrane proximal FnIII domains and the preceding C-terminal 
domain of CHR appear to behave like rigid rods that assume variable relative orientations 
in regards to the membrane plane (Figure 2-15a,b). Ligand binding on the CHR fixes the 
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membrane-proximal domains in a single configuration that facilitates precise and close 
juxtaposition at the membrane level (Figures 2-15d-e, 2-19a,b, 2-21b). 
Our EM studies with full-length gp130 and LIF-R constructs have suggested that the 
dimeric arrangement of the extracellular membrane-proximal domains was significantly 
stabilized by the presence of the receptor trans-membrane regions. As has been shown for 
the erythropoietin receptor, this is likely facilitated by dimerization properties of the 
receptor single-pass α-helices spanning the membrane (Constantinescu et al., 2001b). It is 
thus reasonable to assume that LEP-R and most cytokine receptors are preformed non-
signaling dimers at the cell membrane. Elegant mutagenesis experiments by 
Constantinescu et al. (2001) on the erythropoietin receptor have revealed that the exact 
disposition and pitch of the TM helices is crucial for intracellular signaling 
(Constantinescu et al., 2001a). Given the leptin-induced stabilization and precise 
disposition of the membrane-proximal LEP-R regions observed here, we postulate that 
ligand binding on the membrane-distal regions of receptor dimers is rigidly transmitted 
towards the receptor trans-membrane helices. This likely represents a common 
mechanism for cytokine and hormone receptors to stabilize an intracellular conformation 
that favors Jak trans-phosphorylation.  
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Chapter 3  Structural Flexibility of the Gi α-helical domain in the µ Opioid 
Receptor - Gi Complex 
3.1 Abstract 
The G-protein-coupled receptors (GPCRs) are the largest group of signaling proteins that 
respond to hormones and neurotransmitters. The fundamental event in GPCR signal 
transduction is the formation of an active, agonist-bound receptor and G-protein complex. 
Here, we apply electron microscopy (EM) in order to elucidate the architecture of the µ-
opioid receptor (MOR) in complex with its inhibitory G-protein partner, the Gi (Gαiβγ). 
In comparison with the recent EM study of the β2AR-Gαs complex, MOR-Gi overall 
domain organization as well as AH domain conformational flexibility are in striking 
agreement. We hypothesize that as is the case with β2AR-Gαs complex, the MOR-Gi α-
helical domain will be stabilized in the presence of specific nucleotides such as the 
pyrophosphate mimic foscarnet (phosphonoformate). 2D averages and 3D 
reconstructions of the MOR complex are compared to the β2AR-Gαs complex. The data 
from these studies reveals structural similarities of two GPCRs-G-protein complexes, 
signaling through different Gα subunits: β2AR-Gα through the activating Gαs and µOR 
through the inhibiting Gαi. 
3.2 Introduction  
Proteins embedded in the cell membrane, serve as the interface between the extracellular 
and the intracellular environment of the cell. GPCRs are amongst the largest and most 
diverse family of proteins that are able to detect extracellular signals such as photons, 
ions, small organic molecules and protein-ligands (Fredriksson et al., 2003). GPCRs are 
activated upon ligand binding on their extracellular portion. This results in 
conformational changes in the receptor’s transmembrane region, resulting in the 
activation of complex intracellular networks and initiating cellular response. Recent 
advances in obtaining detailed structural information of receptors from this family have 
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begun to unravel the complicated mechanisms of activation of these transmembrane 
machineries. In addition, the availability of structures from several GPCRs allows for 
comparative analysis not only on their three dimensional fold but also in their functional 
relationship. 
Opioid receptors are GPCRs that exert a wide range of actions in the central nervous 
system such as regulation of pain, euphoria, sedation, and cough suppression, making 
them important pharmacological targets (Katzung, 2009). Based on their pharmacology 
and tissue distribution the opioid receptors are grouped into 3 classes, the morphine (µ), 
vas deferens (δ) and ketocyclazocine (κ) classes (Satoh and Minami, 1995). 
MORs can be activated by endogenous peptides such as endorphins and enkephalins 
(Waldhoer et al., 2004). On the other hand, opioid alkaloids, such as morphine and 
codeine, and their derivatives bind on MORs and are the most effective in relieving acute 
and chronic pain. Unfortunately, these medically effective drugs are also highly 
addictive, contributing to the illicit drug market worldwide and are major contributors to 
death by intravenous overdose. Therefore, tolerance and dependence are the limiting 
factors in their clinical efficacy and developing new drugs is of crucial importance to 
improve human health. MORs can activate a diverse set of downstream signaling and 
regulatory pathways to mediate both their beneficial and adverse effects (Waldhoer et al., 
2004). To initiate intracellular signaling, MORs require the activation of their G-protein 
counterparts. G-proteins are guanine nucleotide binding proteins that are capable of 
hydrolyzing the guanosine triphosphate (GTP) to guanine diphosphate (GDP), thus 
shuffling between active and inactive states, respectively (Coleman and Sprang, 1996). 
Heterotrimeric G-proteins are composed of 3 types of subunits, the α subunit (39-52kDa), 
the β subunit (37kDa), and the γ subunit (8kDa), each made by either a different gene or 
as a result of alternative mRNA splicing. G-proteins are classified based on the identity 
of the α subunit which is localized to the membrane by a cysteine-linked palmitoyl group 
(Coleman and Sprang, 1996). The Gα subunits consists of a Ras domain,with a GTP-
binding pocket, and a small α-helical bundle domain. The structural characteristics of the 
Ras domain include a glycine-rich ‘P loop” that surrounds the di- and triphosphate of the 
guanine nucleotide and two segments termed switch I and switch II. Switch I contains a 
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conserved arginine and switch II a conserved glutamine and they both change 
conformation upon GTP hydrolysis (Sprang, 1997). In its inactive state, the α subunit is 
GDP-bound and has a high affinity for the βγ dimer. When the ligand binds to the 
receptor, the heterotrimeric G-protein associates with the receptor, GDP is exchanged for 
GTP within the Gα subunit and heterotrimer dissociates into Gα-GTP and Gβγ. The 
activated Gα subunit is then able to bind downstream effector proteins and exert its 
functions (Figure 3-1) (Van Eps et al., 2011). The β subunit and the γ subunit are tightly 
associated where the γ subunit makes farnesyl or geranylgeranyl contacts to the 
membrane lipids, localizing the βγ dimer to the membrane (Sprang, 1997). Structural 
differences between the 5 isoforms of Gβ and the 11 isoforms of Gγ found in mammals 
could provide selectivity for different GPCRs. Furthermore, the βγ dimer can also have 
signaling capabilities. For example Gβγ is shown to activate adenylyl cyclase, potassium 
channels and certain isoform of phospholipase C (Sprang, 1997). 
 
 
Figure 3-1 The activating cycle of the G-protein accompanied by exchange of GDP 
for GTP. 
The G-protein heterotrimer in its inactive state is composed of Gα and Gβγ and is in GDP 
bound state. Upon association with the receptor the nucleptide leaves the G-protein and 
the nucleotide-free receptor-G-protein complex is formed. Gα is activated upon GTP 













The µ-opioid receptor couples to Gi, the inhibitory subunit of adenylyl cyclase (AC) 
which is also responsible for exerting its analgesic effect (Raffa et al., 1994). The Gi 
family of proteins exhibit the most diverse functionalities and can be further subdivided 
into 5 groups (Gi, o, t, g and z). The α subunit of the G protein undergoes a cycle of 
nucleotide exchange and hydrolysis when activated by the receptor (Linder, 2004). In 
addition, members of the Gi family, except Gαz, can be ADP-ribosylated by pertussis 
toxin at a cysteine residue, near the carboxy terminus, which inhibits their interaction 
with the receptor (Sprang, 1997). Interestingly, after activation, the receptor is 
phosphorylated which allows for its coupling to a class of proteins termed arrestins, 
which can exhibit both signaling and regulatory functions (Shukla et al., 2011).  
The structure of MOR in complex with a morphinan antagonist, in its inactive state, was 
recently solved (Manglik et al., 2012).  
 
Figure 3-2 Crystal structure of µ-OR bound to morphinan antagonist.  
Left – crystal structure of MOR, side view; green circle – bound morphinan antagonist. 
Right – top view, crystal structure of MOR with bound morphinan antagonist (green 




The crystal structures of other opioid receptors have also been determined in their 
inactive conformations, bound to antagonists (Granier et al., 2012; Wu et al., 2012). In 
addition, the crystal structure of other GPCRs in their active state have also been 
determined (Choe et al., 2011; Palczewski et al., 2000; Rasmussen et al., 2011a). 
Furthermore, a landmark in the field of GPCRs was the successful crystallization of 
β2AR in complex with its Gαsβγ-heterotrimer (Rasmussen et al., 2011b). These structural 
studies have provided important information regarding the association of an activated 
receptor with its G-protein in the process of signaling  
We employed single particle electron microscopy to study the µ-OR-Gi complex aiming 
to understand overall architecture and dynamics of the mechanism of activation of MORs 
and facilitate the crystallization of the MOR-Gi signaling complex. 
3.3 Experimental procedures 
Specimen Preparation and EM Imaging of Negative-stained Samples 
T4L-µ-OR-Gi complex was prepared by Aashish Manglik from the lab of Brian Kobilka . 
All samples were prepared for EM using the conventional negative staining protocol (Ohi 
et al., 2004). Specimens were imaged at room temperature with Tecnai T12 electron 
microscope operated at 120kV using low-dose procedures. Images were recorded at 
magnification of 71,138X and a defocus value of ~1.5 µm on a Gatan US4000 CCD 
camera. All images were binned (2X2 pixels) to obtain a pixel size of 4.16 å on the 
specimen level. Tilt-pair particles from 60° and 0° images were selected using WEB 
(Frank et al., 1996). Particles for only 2D classification of 0° projections were excised 
using Boxer (part of EMAN 1.9 software suite) (Ludtke et al., 1999). 
Two Dimensional Classifications and 3D Reconstructions of T4L-µ-OR-Gi complex. 
The 2D reference-free alignment and classification of particle projections were performed 
using SPIDER (Frank et al., 1996). For all conditions, the 0° particle projections were 
iteratively classified into multiple classes for 10 cycles. For the 3D reconstructions, in a 
first step we used the random conical tilt technique (Radermacher and Ruiz, 2006) to 
determine the initial 3D maps by back-projection of tilted particle images belonging to 
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individual classes. After a first round of angular refinement, corresponding particles from 
the untilted images were added, and the images were subjected to another cycle of 
refinement. Finally, we used FREALIGN for the further refinement of the orientation 
parameters and reconstruction.  
Molecular Modeling 
The crystal structure of the T4L-µ-OR (Figure 3-2) was fit into the EM density as a rigid 
body. Because of the presence of a detergent micelle, which accounted for a significant 
density surrounding the µ-OR, all docking operations were performed manually with 
visual inspection of the best fit. 
3.4 Results 
Overall Architecture of the T4L-µ-OR-Gi complex 
In the first part of the analysis we aimed to define the overall architectural organization of 
the T4L-µ-OR-Gi complex by comparing it to the T4L-β2AR-Gs complex. Initially, the 
homogeneity of the protein preparation was assessed by visualizing the T4L-MOR-Gi 
complex by negative stain EM. The negatively stained micrographs revealed a 




Figure 3-3 Raw image of the T4L-MOR-Gi complex. 
The micrograph reveals monodisperse particle projections of the T4L-MOR-Gi complex. 
After boxing the particle projections we performed a reference-free 2D classification. 
Initially, the ~26,000 particle projections were classified into 200 classes (Figure 3-4 a). 
In a second step, we removed particles from the misaligned classes, and performed a 
second round of classification with the remaining 19,200 particle projections (Figure 3-
4b,c). We divided the particles into both 100 and 50 classes in order to see if number of 
different populations increases with more classes. Since the 100 and the 50 classes 
contained similar averages, we decided to use the 50 classes classification for our 
subsequent analysis where the particle number per class would be higher. The 2D 
classification revealed characteristic class averages with an overall density displaying 






Figure 3-4 2D reference-free alignment and classifications of particle projections of 







a, Initial 2D classification of ~26,000 particle projections divided into 200 classes.b, 
Secondary 2D classification of the remaining ~19,200 particle projections divided into 
100 classes. c, Secondary 2D classification of the remaining ~19,200 particle projections 
divided into 50 classes. 
 
In our initial analysis, we wanted to compare the 2D class averages from the β2AR-Gαs 
to the 2D class averages of the MOR-Gαi complex side-by-side. Similarly to the β2AR-
Gαs complex, the MOR-Gαi complex also assumed a preferred orientation on the carbon 
support. This allowed for the side-by-side comparison of the two complexes and aided 
tremendously in the domain assignment within the MOR-Gi complex (Figure 3-5). Both 
complexes were similar in size and showed distinct densities that could be easily 
compared and contrasted, while the domain assignment of β2AR-Gαs complex served as 
guidance (Figure 3-5). The distinct features of the class averages in these preferred 
orientations allowed us to assign the specific features of the complex in its negative stain 
profile, directly compared to the β2AR-Gαs complex.  
As in β2AR-Gαs complex, the central oval density was attributed to the MOR within the 
detergent micelle (Figure 3-5a,b- left). In addition, some of the class averages also 
revealed a small protruding density at one end, which was attributed to the T4 lysozyme 
(T4L) (Figure 3-4 and 3-5). The engineered T4L served to replace the unstructured 
extracellular N terminus of the receptor and also helped with the particle alignment. 
Interestingly, in few of the class averages, the density for the t4L was missing. The 
reason for the absence of T4L was attributed to the sensitivity of the particles to the out-
of-plane tilting, the so-called “rock” and “roll”, unevenness of the carbon support and/or 
the relative flexibility of the linker between T4L and the receptor. These effects have 
been well documented in the earlier EM study of the β2AR-Gs complex (Westfield et al., 
2011). Although, the crystal structure of the µ-opioid receptor suggested the existence of 
a parallel dimer species (Manglik et al., 2012), the overall architecture of the MOR-Gi 
complex in solution suggests otherwise. Here, the 2D EM class averages reveal only a 




Figure 3-5 Side-by-side comparison 2D class averages from β2AR-Gαs complex and 
MOR-Gαi complex. 
a, representative 2D class averages form the β2AR-Gs complex in a nucleotide-free state 
(Courtesy to Gerwin Westfield). b, representative 2D class averages of MOR-Gi complex 
in a nucleotide-free state .c, model for the domain assignment in the T4L-MOR-Gi 
complex with both invisible AH domain (left) and fully extended AH domain (right). 
 
As in the case with β2AR-Gαs, the additional density around the receptor is attributed to 
the large detergent micelle (Rubinstein et al., 2007). 
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The Gi heterotrimer was assigned to lie on the diametrically opposite side of the T4L 
with at least 2 domains clearly visible in each of the class averages (Figure 3-5). The 
domain that visibly made a connection to the micelle of the receptor was attributed to the 
catalytical domain of the Gi, the Ras domain. Also, in few of the class averages, an extra 
density was observed protruding below the Ras domain (Figure 3-5). In the crystal 
structure of the Gi heterotrimer, the AH domain is found in this extended conformation 
and below the Ras domain (Wall et al., 1995). In addition, the crystal structure of Gαs-
GTPγS alone reveals the same positioning of the AH domain (Sunahara et al., 1997). 
Therefore, we assigned this additional density to the AH domain (Figure 3-5 right 
panels). This visual variability of the AH domain in the 2D class averages was also 
observed in the β2AR-Gαs complex EM studies (Westfield et al., 2011) and was shown to 
be nucleotide-dependent. Therefore, observing an inherent flexibility in another GPCR-
G-protein complex is not surprising. Finally, the Ras domain also appeared to make a 
contact with an additional larger domain, not connected to the receptor. We assigned this 
domain as the βγ subunit of Gi heterotrimer (Figure 3-5). 
 
The flexibility of the AH domain of Gi 
One of the main aims of these studies was to observe the positioning of the AH domain in 
the context of the MOR-Gi complex and compare it directly to the β2AR-Gαs complex. 
Interestingly, careful examination of the 2D class averages from our reference-free 
alignment also revealed variability in the positioning of the density corresponding to the 
AH domain with respect to the Ras-like domain (Figure 3-6). 
 
Figure 3-6 Representative class averages displaying the variability in the positioning 




The position of the AH domain with respect to the Ras-like domain and the βγ varied 
with many degrees. In some class averages the AH domain was not visible likely due to 
its positioning directly on top of the Ras domain (Figure 3-5 left). In the class averages 
where the AH domain was clearly visible, it assumed various positions with respect to the 
βγ dimer (Figure 3-5). The striking similarities between the two GPCR-G-protein 
complexes of β2AR-Gαs and MOR-Gi, respectively, suggest an inherent flexibility of the 
AH domain. Further biochemical studies would be needed in order to elucidate the 
significance of the striking conformational changes of the AH domain in complex with 
the receptor. The possibility of its role in activation of the G-protein is plausible as 
previous studies suggest that the AH domain may limit the accessibility of the 
nucleotides within the nucleotide exchange pocket on the Ras-like domain. 
The significance of homo-oligomers of the MORs 
Past structural and functional studies have suggested the existence of functional homo-
dimers of the MOR (Granier et al., 2012; Manglik et al., 2012). In the case of the β2AR, it 
was shown that the existence of such species in the signaling context is unjustified 
(Rasmussen et al., 2011b; Westfield et al., 2011). EM and other biochemical and 
biophysical studies support the fact that the detergent micelle contains only one receptor. 
However, the gel filtration profile of the purified MOR-Gi complex also revealed some 
higher order species and we wanted to investigate further their overall conformation. We 
visualized ~4,500 particle projections, which were classified with a reference-free 
alignment into 100 classes (Figure 3-7a). The class averages displayed both monomers 
and what appeared as dimers of two complexes next to each other. However, upon closer 
examination of the classes containing the dimeric species, it appeared that the two 
detergent micelles, containing the receptors, were positioned at the opposite ends of the 
particles, forming anti-parallel dimers. (Figure 3-7b). Also, the βγ subunits of one 
complex seem to be making a ‘weak’ connection to the micelle of the opposite 
receptor/complex unit. These anti-parallel conformations were not observed in 
subsequent purifications and they certainly do not represent functional units.  The 
dimerization artifact could be attributed to hydrophobic groups within the βγ that are 
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being inserted in the micelles but whether this effect is concentration dependent is not 
entirely clear at this point. 
Interestingly, the MOR was crystallized as a parallel dimer, most likely due to the lowest 
energy needed for the crystal packing (Manglik et al., 2012). In our first analysis of the 
MOR-Gi complex, solubilized in detergent and analyzed with negative stain EM, we 
observed both monomeric and dimeric particles of the MOR-Gi complex. A closer look 
at the dimeric formations revealed that the dimer is actually formed in an antiparallel 
fashion (Figure 3-7).The EM analysis provides a view of the complex in solution and an 
anti-parallel dimer would have no physiological significance. Therefore, the parallel 









Figure 3-7 The artificial antiparallel dimer of the MOR-Gi complex. 
a, 2D class averages of the ~4,500 particle projections grouped into 100 classes. b, side-
by-side comparison of the dimer to the monomer also revealing the weak interaction 
between the βγ subunit of one complex and the receptor micelle of another. 
3.5 Three-dimensional reconstructions of the T4L-MOR-Gi complex. 
In order to further investigate the overall architecture of the complex and obtain more 
discernable details of its conformations, we used the random conical tilt approach to 
calculate a three dimensional reconstruction of the complex. Initial 3D reconstructions 
were calculated from particle projections either with or without the density corresponding 
to the AH domain below the Ras-like domain (Figure 3-8 a, b). The initial reconstructions 
were in excellent agreement to the corresponding 2D class averages (Figure 3-8). 
Furthermore, the 3D reconstructions where the AH domain is either invisible or 
positioned below the Ras-like domain, closely resemble the 3D volumes for the β2AR-Gs 
complex (Figure 3-8). We could not perform experiments in the presence of nanobody 37 
to enhance the density of the AH domain due to time constraints. Nevertheless, our 3D 
volumes of the MOR-Gi complex are in excellent agreement with the 3D volumes of the 
β2AR-Gs complex in the absence of Nb37. In addition, the 3D reconstruction from the 
population of particle projections with “fully-extended” AH domain, provides enough 
volume below the Ras-like domain to fully accommodate the AH domain in this region. 
It should be noted that one of the disadvantages of negative stain is that the proteins lose 
the hydration shell and collapse on the carbon support. Therefore, the AH domain does 
not appear to have a designated density protruding either in the front or the back of the 
3D reconstructions. More experiments with stabilizing nanobodies or nucleotides are 
needed to confirm our findings. However, these initial structural studies provide an 











G-proteins but also into the flexibility of the AH domain in the context of the activated 
receptor. 
 
Figure 3-8 Three-dimensional reconstructions of the MOR-Gi complex in a 
nucleotide-free state. 
a, Representative class averages of the corresponding 3D reconstructions in b, of particles 
in each category to show the variability in the positioning of the AH domain in the 
nucleotide-free complex. In the reconstruction to the left, the AH domain is not visible 
because of its flexibility and highly variable particle population. In the reconstruction to 
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the right, the AH domain is modeled within the EM density and right below the Ras-like 
domain of Gi, as suggested in the 2D class averages. c., 3D reconstructions of the β2AR-
Gs complex with the docked crystal structure, also displaying the variability in the 
positioning of the AH domain. (c., Courtesy of Gerwin Westfield). 
3.6 Discussion  
The EM studies of the MOR-Gi complex provide important insights into the inherent 
flexibility of AH domains of Gα proteins. The crystal structures are able to provide 
snapshots of these complexes in certain nucleotide states. However, the flexibility of 
distinct domains within the complexes that reflect the dynamics of such protein 
machineries have just begun to unravel. Despite the artifacts from negative staining such 
as protein dehydration and particle collapse, single particle analysis allows for obtaining 
new insights into the dynamic features of inherently flexible protein assemblies. Here, we 
visualized the MOR-Gi complex, embedded in negative stain with EM and applied single 
particle analysis to elucidate overall domain organization as well as assess the flexibility 
of the AH domain in the Gαi subunit.  
The 2D class averages of MOR-Gi complex and the side-by-side comparison with the 
β2AR-Gs complex allowed for the domain assignment. Our analysis revealed striking 
similarities in the overall architecture of the two GPCS-G-protein complexes, β2AR-Gs 
and MOR-Gi (Figure 3-5). As in the case for β2AR-Gs, the 2D class averages revealed a 
large density in the middle, corresponding to the µ-opioid receptor (MOR) solubilized in 
detergent. Additionally, an N-terminal T4L was present in some class averages and 
missing in others. The well documented artifact due to the particle “rock” and “roll” 
(Westfield et al., 2011) is contributing to this partial visibility in few of our class 
averages. Moreover, we were able to distinguish the Ras domain from the Gα subunit 
making its connection to the receptor as well as the variably visible density contributing 
to the AH domain of Gαi. The globular density contributing the AH domain was 
observed in various positions compared to the Ras domain, from fully extended to 
completely positioned on the Ras domain (Figure 3-6).  
Interestingly, the AH domain displays the same inherent flexibility in a nucleotide-free 
state of the complex as is the case with β2AR-Gs complex. The mode of action of Gs and 
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Gi proteins is different in how they are able to effect downstream signaling targets either 
activating adenylyl cyclase (AC) or inhibiting AC, respectively. Indeed, the flexibility of 
the AH domain was inferred in a study with the activated rhodopsin-Gi complex as a 
change in the relative distances between the Ras and AH (Van Eps et al., 2011). In 
addition, the EM and Deuterium exchange coupled to mass spectrometry (DXMS) studies 
of the β2AR-Gαs complex (Westfield et al., 2011) (Chung et al., 2011) also support the 
receptor-induced AH domain flexibility of the G-protein. In addition, it has been 
demonstrated that the nucleotide exchange lies in the interface between the Ras and the 
AH domain (Sprang, 1997) and the presence of the AH domain slows the nucleotide 
exchange (Markby et al., 1993). Therefore, it is possible that the AH domain may play a 
role in the activation of the G-protein by capturing the nucleotide when positioned 
directly on Ras or providing an escape route of the nucleotide when in fully-extended 
conformation. Furthermore, the functional role of the structural flexibility of the AH 
domains could be explained in the context of bacterial toxins’ mode of action as well as 
nucleotide analogs able to lock the AH domain in certain positions and affect 
downstream signaling.  
More studies need to be conducted to fully assess the effect of different nucleotides on 
the stability of MOR-Gi complex. However, considering the conservation in the overall 
domain organization between β2AR-Gs and MOR-Gi, as well as the inherent flexibility of 
the AH domains in both Gs and Gi subunits, it is likely that the flexibility of the AH 
domain in the MOR-Gi complex would be affected by nucleotide analogs in a similar 
manner. For example, it is suggested that the binding of PPi-mimic foscarnet substitutes 
for the binding of the α- and β- phosphates in GDP. (Westfield et al., 2011). In addition, 
only foscarnet is able to stabilize the AH domain on Ras by acting as a ligand fragment in 
the nucleotide binding pocket (Westfield et al., 2011). If the activating mechanisms of 
MOR-Gi and β2AR-Gs are indeed similar, one would expect to find the AH domain of Gi 
being stabilized on the Ras domain in the presence of foscarnet which presumably 





Figure 3-9 Different dissociation states of the β2AR-Gs complex in the presence of 
1uM GTPγS. 
Left is fully intact complex, right - fully dissociated G-protein hetertrimer (Courtesy of 
Gerwin Westfieled). 
 
In contrast to PPi and foscarnet, the non-hydrolyzable GTP analog, GTPγS would be 
expected to mimic bound GTP and lead to dissociation of the G-protein from the 
receptor. This was the case for β2AR-Gαs complex (Westfield et al., 2011). 
To facilitate obtaining a high-resolution structure of the MOR-Gi complex, we will also 
investigate the effect of nanobodies on complex stabilization. The nanobodies are 
clonable variable domains of heavy chain only antibodies that can be obtained by 
immunizing a Llama with purified GPCR-G-protein complexes (Rasmussen et al., 
2011a). Nanobody 35 (Nb35) was found to bind at the interface of Gα and Gβγ 
stabilizing the complex and facilitating the crystallization the receptor-G-protein 
complex. More importantly, Nb35 did not interfere with the stability of the AH domain 
(Rasmussen et al., 2011b; Westfield et al., 2011). 
The single particle EM analyses of GPCR-G-Protein complexes serve as a tool to gain 
important insights into dynamic changes taking place upon receptor activation or 
nucleotide exchange in the G-protein. In addition, the EM studies allow for the capturing 
of transient state snapshots of the complex which otherwise may not be present in the 
crystal structure and thus help reveal mechanism of action. 
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Chapter 4 Discussion and Future Directions 
4.1 The leptin receptor system 
Despite the wealth of biochemical information on the leptin/leptin receptor signaling 
pathway, there are many structure-function related questions that remain to be resolved. 
The structural information concerning the atomic detail of the ligand binding domain 
alone and in complex with leptin is still lacking. Increasing the resolution of structures 
for this interaction could also lead to development of small molecule agonists and 
antagonist that can modulate leptin signaling. Additionally, it is still not well understood 
how ligand binding at the extracellular side of the receptor instigates intracellular 
signaling. The details regarding the transmission of structural information through the 
membrane are still lacking. Because LepR relies on intracellularly bound JAK2s for 
signaling, obtaining structural information about the ligand-receptor-kinase complex is 
crucial for our understanding not only of leptin-LepR system but also for the whole 
family of cytokine receptors. 
 
Crystallization trials 
The gene for LepR was discovered and cloned about seventeen years ago by Tartaglia 
and colleagues (Tartaglia et al., 1995). Yet, since then, very limited information 
regarding the structure of the leptin/LepR complex has become available. Because LepR 
is an integral membrane protein, its solubilization and purification have proven to be very 
difficult. In addition, the lack of posttranslational modification mechanisms in bacterial 
cells such as glycosylation, proteolytic maturation of the overexpressed protein or limited 
capacity for the formation of disulfide bridges have also contributed to the difficult 
recombinant production of LepR (Kamionka, 2011). Insect cells and Baculovirus 
expression systems have emerged as a novel tool for production of recombinant proteins 
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with the necessary posttranslational modifications (Becker-Pauly and Stocker, 2011). 
However, the quantities of the recombinant expressed proteins and their solubilization 
can still pose challenges for the crystallographic studies.  
Portions of the extracellular domains of other members of the class I cytokine receptors 
have been successfully crystallized. For example the N-terminal five domains of LIF-R in 
complex with LIF have been crystallized, revealing an addition LIF-receptor interaction 
within the Ig-like domain (Huyton et al., 2007). The structure of the ligand interacting 
domains of GCSF-R in complex with GCSF was also solved (Tamada et al., 2006). In 
addition the entire ecto domain of the gp130 was successfully crystallized (Xu et al., 
2010). These crystallographic studies give precedent for the crystallization of parts or the 
entire the region of LepR.  
 
Flexible regions  
The EM negative stain studies on the full length extracellular LepR revealed a flexible 
hinge, at the level of CHR2 which is stabilized upon ligand binding. Moreover, long 
linkers at the very N-terminus as well as within the CHR1 putative module could also 
present potential sites of flexibility. Receptor’s sequence analysis and homology 
modeling contribute to this hypothesis. In fact, sequence analysis of LepR reveals long 
linkers at the N-terminal region of the receptor that are not attributed to any domain. 
There are ~40 residues between the end of the signal sequence and the first putative 
domain of the CHR1 module. Additionally, a stretch of 57 residues divides the distance 
between the two CHR1 domains within the first module (Figure 4-1).  Furthermore, the 
2D class averages from both full length and truncated extracellular LepR display 
increased “fuzziness” at the very N-terminal tips, also suggesting flexibility in these 
regions.  
Protein engineering can help alleviate the problem of flexibility by adding more 
conformational constraints and rigidity in the receptor. Engineering of shorter constructs 
lacking the flexible regions may aid in the stabilization of the protein and thus enhance 
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the chances of its crystallization. For this purpose, constructs lacking the entire CHR1 
module and one composed only of the CHR2 and IgD could be further examined. 
Preliminary data from the designing, cloning and expression of the CHR-IgD protein 
construct is already available (Figure 4-2).  
 
Figure 4-1 a, Homology model of the entire extracellular domain of LepR and 2D 
class averages of both full length and truncated extracellular Lep-R. 
a., Homology model of the entire ecto domain of LepR; all seven domain D1-D7 are 
modeled according to known structures of the same family of receptors. The first 57 
residues, termed D0, are also modeled to a random crystal structure in the PDB (Courtesy 
of Steven Z. Chou). b, class averages of full length extracellular and truncated LepR 





Figure 4-2 Raw images of purified CHR2/IgD construct. 
Raw images from negatively stained particles from the purified protein reveal a 
homogeneous population of monodispersed particles with the characteristic kink at the 
level of CHR2 domain. In addition, the optimized protocol for the purification of the full 
length extracellular LepR is also applicable for the shorter constructs, allowing for the 
production of large quantities of protein that are also needed for the crystallization trials.  
 
Heterogeneity 
In addition, our analysis of the leptin/LepR complex consistently revealed complexes 
composed of two receptor chains and two ligands and a very small population (~15%) of 
single receptor chains bound to leptin. Because of the dynamical process of these 
interactions and the shape of the molecules, we were never able to separate the two 
populations with any biophisical method. Furthermore, it is possible that the monomer-
dimer heterogeneity is not present at higher protein concentrations. 
Previous mutagenesis studies on the ligand binding domain of the leptin receptor define 
important functional residues that play roles in leptin binding and LepR activation 
(Iserentant et al., 2005; Peelman et al., 2006). Precisely, a mutation (L503A) within the 
CHR2 domain of the receptor completely abolishes leptin binding while a (L370A) 
within the Ig-like domain leads only to an impaired ability to activate downstream 
signaling. Interestingly, in the EM studies of the leptin receptor signaling complex, the 
L370A mutant is still able to bind leptin, thus, stabilizing the hinge region at the CHR2 
while unable to form the quaternary complex. The L370A mutant can be useful in the 
crystallization of the complex by creating a homogeneous population of binary 
complexes consisting of one receptor chain bound to one leptin. 
Furthermore, adding a leucine zipper at the C-terminus of the extracellular portion of the 
receptor could create a homogeneous population of the quaternary signaling complex. An 
engineered GCN4 coiled-coil will aid in the stabilization of the quaternary complex by 
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not allowing the dissociation due to the weaker interaction of epitope 3 of leptin and the 
Ig-like on the receptor.  The design and cloning of this construct is already in progress. 
 
Longer constructs of the LepR 
The recent EM studies of the extracellular leptin receptor signaling complex provide 
important insights into the mechanism of activation upon binding of leptin. Previous 
biochemical studies suggests that the receptor exists a preformed dimer and binding of 
ligand induces conformational changes that result in activation of downstream signaling 
(Devos et al., 1997; Zabeau et al., 2005).We hypothesize that the receptor exists as a 
preformed dimer at the plasma membrane. Upon leptin binding at the extracellular side, a 
conformational change on the receptor is transmitted through the membrane and allows 
for the precise positioning of intracellulary bound JAK2s to transphosphorylate and 
activate downstream signaling. The EM studies of the extracellular LepR  clearly 
demonstrated that the extracellular LepR exists as a monomer and it dimerizes upon 
ligand binding. Therefore, it will be interesting to examine further whether the 
dimerization interface can be attributed to the transmembrane helices or the intracellular 
receptor tails. For this purpose, longer receptor constructs will aid in the analysis. 
Moreover, reconstitution of the full-length receptor in the presence of the ligand and the 
Janus kinase could provide invaluable insights onto how the kinase gets activated. In 
addition, an in vitro reconstitution of all the components of the signaling machinery could 
also provide more clues onto how transmembrane receptors translate ligand-induced 
structural information through the membrane to instigate downstream signaling. 
 
4.2 The µ-opioid receptor - Gαi complex system 
In both the β2AR-Gαs and the µ-OR-Gαi complexes, the AH domain of the α subunit of 
their respective G-protein seems to possess an inherent flexibility. The flexibility of the 
AH domain can be implicated in the activation mechanism of the G-protein. Because G-
proteins play a central role in signal transduction and mediate the extracellular signaling 
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through the largest family of receptors, the GPCRs, they are poised for further 
examination.  
 
The flexibility of the α-helical domain of the G-protein 
Crystal structures of G-proteins reveal important insights into their activation mechanism. 
Conformational changes can be exerted within three regions, termed Switch I-III, which 
lie within the Ras domain and Switch I connects the Ras to the AH domain (Sprang, 
1997). The nucleotide exchange occurs at the interface between the Ras and the AH 
domain and it is presumably dependable on their uncoupling. In fact, it was demonstrated 
that the rate of nucleotide exchange is slowed in the presence of AH domain suggesting 
the role of the AH domain in the activation of the G-protein (Markby et al., 1993). 
Additionally, experiments with chimeric Gα subunits from plant G-proteins showed that 
the more disordered AH domain contributes to higher basal activity (Jones et al., 2011). 
In other words, a more extended conformation, where the AH domain is further away 
from the Ras domain, provides for more accessibility of the nucleotide to be shuffled in 
and out. Moreover, in the crystal structure of the β2AR-Gαs complex, the βγ subunit does 
not interact with the receptor where the Gαs contacts the receptor with both its N- and C-
termini (Rasmussen et al., 2011). A snapshot of the G-protein bound to the receptor in its 
nucleotide-free state also reveals the displacement of the AH domain away from Ras 
thereby, suggesting their dissociation and exposing the nucleotide binding pocket. Aside 
from the structural information about the AH domain in the crystal structure of the 
β2AR-Gαs complex, past biochemical and biophysical studies also have revealed the 
flexibility of the AH domain. In one study, the author applied double electron-electron 
resonance spectroscopy and measured the change in probes between the Ras and the AH 
domains in Gαi. Interestingly, the increase in distance between the two domains 
corresponded with nucleotide release (Van Eps et al., 2011). In hydrogen deuterium 
exchange studies, the solvent accessibility at the Ras-AH domain increases upon receptor 
binding (Chung et al., 2011). Thus, it appears that upon receptor activation the AH 
domain moves away exposing the nucleotide binding pocket. Moreover, the single 
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particle EM studies of the β2AR-Gαs complex also revealed that the conformation of the 
AH domain undergoes from being stabilized on the Ras domain in the more inactive 
state, to becoming more flexible in a fully extended orientation in active state. In fact, the 
MOR-Gi complex also exhibits flexibility of the AH domain. It seems likely that the 
separation of the AH domain from Ras is correlated to release of nucleotide in all of the 
above mentioned studies.  
 
AH domain as a drug target 
G-proteins have a high degree of sequence similarities with the greatest conservation 
being  within the Ras, particularly the switch regions, and the least conservation within 
the AH domain (Dohlman and Jones, 2012). The EM studies of the MOR-Gi complex 
were able to reveal and confirm the previously suggested flexibility of the AH domain of 
Gαi. In addition, it has been demonstrated that the presence of the AH domain slows the 
nucleotide exchange within the α subunit (Markby et al., 1993). Interestingly, the crystal 
structure of a plant G-protein that is structurally similar to its mammalian counterparts, 
reveals a self-activating function attributed to the intrinsic disorder within the AH domain 
(Jones et al., 2011). Therefore, it is possible that the AH domain plays an important role 
in the activation of the G-protein, making it a potential drug target. 
The sequence variability within the AH domains makes them attractive pharmacological 
targets for finding small molecules that can bind to unique residues and potentially 
modulate signaling. In addition, finding potential downstream binding partners that 
uniquely interact with the AH domain of the Gα could also provide new modes of 
regulation of G-protein signaling. 
Thus, recent advances in structural biology provide new opportunities for developing 
novel therapeutics not limited only to the receptors. With the growing understanding the 
role of the AH domain on the activity of the G-proteins come new possibilities for 




4.3 Concluding remarks 
The investigation of the signaling complex between leptin and its receptor with electron 
microscopy has provided important insights in the activation mechanism not only for the 
leptin system but also for the rest of the class I cytokine members. The structural analysis 
from electron microscopy allowed for the visualization of the flexible regions on the 
leptin receptor, specifically at the CHR2 domain, which are stabilized upon ligand 
binding. In addition, the stoichiometry of the complex which was a matter of debate for a 
long time was also deduced. Most importantly, the electron microscopy allowed for the 
observation of transient states of the proteins, forming the signaling complex. Here, a 
technique such as x-ray crystallography could have provided only a snapshot of the 
mechanism. Yet, detailed and high resolution structural information between the ligand 
and receptor binding domain could provide very useful information for the development 
of novel therapeutics. Thus, further investigation with x-ray crystallography and/or high-
throughput screening for potential drugs is needed to gain more understanding on how 
the leptin signaling can be modulated. 
The electron microscopy studies of the MOR-Gi complex will not only aid in the 
crystallization efforts of the complex but also extend the previous observations of the 
flexible nature of the AH domain. A crystal structure of the MOR-Gi complex would 
undoubtedly provide a high resolution information about the AH domain interaction with 
the rest of the complex. However, further studies regarding the AH domain can also shed 
light into development of novel therapeutics. Small molecule and protein-protein 
interaction studies would be an invaluable addition to our further understanding of the 
mechanism of action of G-proteins. 
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Structural Studies of Isobutyryl Co-A Mutase Fusion – A G-protein Chaperone 
*This project has been in collaboration with Ruma Banerjee’s Lab at University of 
Michigan.  
 
Isobutyryl-CoA mutase (ICM) is a radical enzyme that uses Coenzyme B12 to catalyze 
carbon skeleton rearrangements. It is a α2β2-heterotetramer that catalyzes the 
rearrangement of isobutyryl-CoA to n-butyryl-CoA. 
The Banerjee Lab has shown that ICM is fused to the P-loop GTP-ase in >70 bacteria and 
named this protein Isobutyryl Co-A Mutase Fusion (IcmF). Structural information about 
the domain organization and interdomain interaction in this newly discovered protein is 
lacking. I have been exploring these interactions using purified protein of the holo 
complex of IcmF using negative stain EM.  
I investigated different constructs of the complex, in the presence of different nucleotides 





Figure A 1 Reference-free alignment of the holo ICMF complex. 
19,515 particle projections classified into 40 classes. 
 
Figure A 2 Reference-free alignment of Apo-IcmF – 4,688 particle projections split 





Figure A 3 Reference-free alignment of IcmF_Apo_GDP_IcsobutyrylCoA – 3,226 




Figure A 4 Reference-free alignment of truncated IcmF, lacking the B12 binding 
domain – 14,588 particle projections into 100 classes. 
 
Figure A 5 Reference-free alignment of MeaI, a single domain of IcmF, possibly 




Figure A 6 Gallery of different IcmF conformations 
During our analysis of the 2D class averages of the holo complex, we observed that while 
one half of the molecule remained consistently similar when compared between class 
averages, the other half varied dramatically. We wanted to further investigate this 
phenomenon and calculated a three dimensional reconstructions using the Random 
Conical Tilt approach. The three dimensional envelop closely resembles the 2D averages. 
However, due to the limited biochemical data, we could not explain the significance of 
the “movement” od one of the domains. 
In conclusion, due to the limited biochemical information, our EM results were 







*This project has been in collaboration with Bob Fuller Lab at University of Michigan, 
Ann Arbor. 
 
Mutations in human orthologs of the yeast VPS13 result in hereditary disorders chorea 
acanthocytosis and Cohen syndrome. VPS 13 functions to transport proteins to the 
vacuole in yeast and also plays an important role in the formation of prospore membrane 
that eventually gives rise to spores. Because of the established role of yeast VPS13 in 
vacuolar transport, it has been inferred that the human phenotypes result from 
comparable defects in membrane transport. 
We carried out some initial EM negative stain analysis of VPS13 to gain more insights 
into its overall topology. We carried out the 2D classification with reference-free 
alignment and split the 7,639 particle projections into 50 classes (Figure B 1). 
The class averages revealed a highly elongated and flexible molecule. Some of the 2D 
averages revealed a distinct loop at one end and a characteristic hook at the other 
diametrically opposite end. However, because of the highly flexible nature of the 
particles and their subsequent alignment, these features were lost form most of the 
classes. We attempted to isolate only these averages that clearly displayed either the loop 
or the hook and reclassify the particles with a subsequent round of reference-free 
classification. As a result we split ~3,000 remaining particles into 15 classes and 





Figure B 1 Reference-free alignment of VPS13 - ~7,600 particle projections 
classified into 50 classes. 
 
Figure B 2 Reference-free alignment of VPS13 - ~3,000 particle projections 





In addition, we generated three-dimensional reconstructions, using the Random Conical 
Tilt Approach from three classes that most clearly displayed both characteristic features 
(Figure B 3). 
 
 
Figure B 3 three-dimensional reconstructions from the respective 2D class averages, 
using Random conical tilt approach. 
 
In conclusion, these analysis require further and more thorough investigation. 
Additionally, optimizing sample preparation and staining is also of critical importance in 
order to aid in the negative stain analysis. 
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